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ABSTRACT 
Viewing the provision of TB-HIV integrated services from the perspectives of TB/HIV clients can 
help to identify ways to enhance the provision of these services. The aim of this study was to assess 
the provision of TB/HIV services including PMTCT from clients perspectives in order to make 
recommendations on ways to enhance the provision of TB/HIV/PMTCT services at facility and 
community level. Method:  Secondary data analysis was undertaken on a survey that was part of a 
cross-sectional study conducted in 2008 in Sisonke district, a rural district of KwaZulu Natal 
province, South Africa. Exit interviews were completed by 274 clients accessing TB, HIV and 
PMTCT services in 10 selected facilities in Sisonke district. A questionnaire that had both closed 
and open-ended questions was used for exit interviews. Ethical clearance of the study was originally 
obtained from the Ethics Committee of the University of the Western Cape. The researcher sought 
permission from the custodian/owner (primary researcher) of the data. The researcher also adhered 
to maintaining data integrity including the confidentiality procedures as defined in the primary study.  
In analysing the data it was checked completeness and internal consistency. The quantitative part of 
the data was stratified, cleaned and coded. The qualitative part of the data was reviewed repeatedly 
and clustered. The measures of central tendency like frequency, means, median and standard 
deviation were used for continuous data while categorical data were analysed with frequency and 
proportions. The Chi-square test was used to assess the association between depend and independent 
variables. 
Results 
The results of this study show that the respondents preferred accessing integrated TB-HIV / PMTCT 
services. Most of the respondents, especially a majority of younger respondents comprising of 
PMTCT (66.7%), HIV (29.8%) and TB (30.8%) categories reported that they were educated on HIV 
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matters. Also, most of the younger respondents (18 – 30 years) among the PMTCT category (74.3%) 
and most of the older respondents (older than 30 years) of the pre ART & ART category (71.2%) 
reported that they were educated about TB matters.  
In general, the majority ( 90 %) of the respondents  preferred TB/HIV/PMTCT services  to be 
provided at  the same place but a small majority (42%) of the respondents preferred to be seen the 
same clinicians. Most (68%) of the PMTCT younger (18-30 years) respondents preferred to receive 
TB-HIV integrated care at their homes while 70% and 68% of HIV and TB older respondents (>30 
years) preferred to receive TB and HIV services at their homes. Viewing the advantages, 
disadvantages and barriers for accessing TB/HIV/PMTCT integrated services, there is a 
proportionate distribution in the responses amid the categories though the female respondents 
comparatively take the lead in reporting about their experiences in accessing TB/HIV/PMTCT 
integrated services. In this study, majority of the respondents demonstrated that they access good 
integrated TB-HIV / PMTCT services both at the facilities level and at home. Providing integrated 
TB-HIV / PMTCT services is widely accepted. Majority of the respondents especially the younger 
females preferred to continue receiving TB-HIV integrated care at their homes in comparison with 
older respondents. 
Conclusion 
Most of the respondents comprised of females aged less than 30 years. These respondents like the 
services provided by the TB-HIV integrated services and want it sustained. They prefer the facilities 
to be in the same location. However, they prefer to consult different clinicians for the two different 
health conditions. The respondents also preferred to have HIV test at the same facility and to be 
visited at home by community health workers in support of the provision of TB/HIV/PMTCT care.
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resistance to the two most effective first-line TB drugs known as rifampicin and 
isoniazid. 
 
 
 
 
 
 
xviii
o Voluntary counselling and testing (VCT): This is a situation in which an individual 
undergoes counselling to enable her / him make an informed decision about being tested 
for HIV, assess their personal risk for HIV and develop a risk reduction strategy in this 
process.
 
 
 
 
 
 
1
CHAPTER 1 INTRODUCTION 
1.0 Introduction 
1.1 Background 
The co-infection of tuberculosis (TB) and human immunodeficiency (HIV) epidemics 
globally and particularly sub-Saharan Africa has led to dramatic increases in morbidity and 
mortality associated with both infections (Gandhi, Moll, Lalloo, Pawinski, Zeller, Moodley et 
al.,2009). Tuberculosis infection is currently the main cause of morbidity and mortality 
among HIV-infected clients (Mukadi, Maher & Harries, 2001). Although there have been  
successful programmes related to TB prevention and treatment, there has been a 
comparatively high mortality rate of HIV due to TB co-infection ranging between 25% - 40% 
prior to the establishment of antiretroviral therapy (ART) (Mukadi et al.,2001). However, 
there are improvements in providing ARTs resulting in declining mortality rates of up to 
55%among TB-HIV co-infected patients with early initiation of ARVs in TB coinfected 
patients as compared with sequential therapy, as demonstrated by the SAPIT study (SAPIT, 
2008). .  It was projected that in the year 2007, just prior to the study in which the survey 
reported here was conducted, 5.27 million people in South Africa were infected with 
HIV/AIDS (UNAIDS, 2008; Department of Health, 2008). KwaZulu Natal (KZN) is one of 
the provinces in South Africa (SA) with the highest rate of TB-HIV co-infection with  two-
thirds of new TB clients testing  positive to HIV (UNAIDS, 2010).  
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Table 1 TB-HIV related profile of KZN 
 
TB-HIV co-infection rate in KZN > 70% 
HIV prevalence rate 37.4% 
HIV incidence rate 2.63% 
Current number of PLHIV in the province 1,622,870 (i.e. 15.8%) of the total population 
Estimate for patients in need of ART 486,861 
Leading cause of death in the province HIV and AIDS related illnesses 
Second leading cause of death in the 
province 
TB 
Current diagnosed TB cases 118,000 (as at 2009, as reported by DOH Annual Report, 
2010) 
KZN TB caseload 1,156 cases per 100 000 population 
Contributors to the high prevalence of HIV Poverty, underdevelopment, very low male medical 
circumcision prevalence, concurrent sexual partnerships, 
transactional sex and late marriage further contribute 
(SANAC, 2011) 
Budget allocated to ART 55% 
Medical male circumcision (MMC) 
attainment 
20% 
Source: Office of the Premier, (2011). 
 
Based on the lessons learned from ProTEST study and the increasing burden of TB-HIV co-
infection worldwide particularly in sub-Saharan Africa, the World Health organisation (WHO) 
and other international bodies advocated for the implementation of collaborative TB/HIV 
activities (WHO, 2004). The WHO developed a policy on collaborative TB/HIV activities that 
has 3 main components as described below:  
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Table 2 The WHO policy on collaborative TB/HIV activities 
A. Establish the mechanisms for collaboration 
- Set up a coordinating body for TB/HIV activities effective at all levels 
- Conduct surveillance of HIV prevalence among people with TB 
- Carry out joint TB/HIV planning 
- Conduct monitoring and evaluation 
B. Decrease the burden of TB among people living with HIV 
- Establish intensified TB case-finding 
- Introduce isoniazid preventive therapy 
- Ensure TB infection control in health care and congregate settings 
C. Decrease the burden of HIV among people with TB 
- Provide HIV testing and counselling 
- Introduce HIV prevention methods 
- Introduce co-trimoxazole preventive therapy 
- Ensure HIV care and support 
- Introduce antiretroviral therapy 
Source: World Health Organisation, (2004).   
 
A viable means of providing integrated TB and HIV services involves a comprehensive 
worldwide approach that links prevention to education and treatment of TB and HIV/AIDS’s 
continuum of care (adherence) in order to enhance treatment outcomes. With respect to the 
prevention and control of the co-infection of TB and HIV, the goal of integration of TB and HIV 
programmes is to improve the quality of the services, ensure the continuity / sustainability of 
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care, as well as prevent and decrease the burdens of the two epidemics on the patients and the 
society (WHO, 2004).  Studies have shown that providing antiretoviral therapy (ART) 
significantly leads to over 80% improvement in TB treatment outcomes and survival rates 
amongst TB-HIV co-infected clients (Manosuthi, Chottanapand, Thongyen, Chaovavanich & 
Sungkanuparph, 2006). Integration of TB/HIV programmes has been found to be cost-effective 
for the effectual management of patients co-infected with TB/HIV (Buthelezi, 2008). However, 
despite the milestones made, at the time of this research  progress had slowed  in the 
implementation of collaborative TB-HIV activities because of a lack of commitment, requisite 
tools and systems to capture monitoring and evaluation data necessary to monitor the progress or 
where applicable, address the gaps (Gunnerberg et al. 2008). 
Globally, there are 14 million people with TB and HIV co-infection (Gunneberg et al.,2008 ; 
USAID, 2009). A study conducted in KZN suggests that the effect of TB/HIV co-infection in 
pregnant women and their infants is important, as there is a 32-fold chance of mortality 
associated with being pregnant and TB-HIV co-infection (Khan, Pillay, Moodley & Connolly, 
2001). Similarly, the consequence of maternal TB and HIV-1 co-infection on foetal 
acquisition of HIV-1 associated with high viral burden and CD4 suppression results to a 
higher overall vertical transmission of HIV-1 and greater risk of rapidly progressive in utero 
and infant HIV infection (Pillay, Sturm, Khan, Adhikari, Moodley  et al. 2004).  
1.2 Problem statement 
The risk of developing active TB in HIV positive people is ten times higher than in HIV-
uninfected individuals, with possible drug interaction-related challenges (Datiko, Yassin, 
Chekol, Kabeto, & Lindtjørn, 2008).  
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Accessing and adhering to treatment poses particular challenges to such patients.  Providing 
successful TB/HIV care ought therefore to consider the needs and views of the clients 
accessing the services, both within and outside the health facilities.  Considering these needs 
involve viewing TB/HIV/PMTCT services from the eyes of the clients, which is not the norm. 
This is the gap that this study sought to  address, in order to  enhance treatment outcomes and 
improve service delivery of TB/HIV/PMTCT care to suit the needs of the patients, who are 
the primary stakeholders. 
1.3  Study rationale 
The benefit of this study is to contribute to the enhancement of the survival of TB-HIV co-
infected people undergoing simultaneous TB-HIV treatment, by viewing the services these 
people receive from their eyes (Ryan, 2008). Viewing the provision of TB-HIV integrated 
services from the perspectives of TB/HIV clients helps to assess the delivery mechanism of 
TB/HIV services, in order to identify factors that could contribute to enhanced performance of 
facilities in relation to implementation of the policy on collaborative TB/HIV activities. The 
enhanced performance of TB-HIV facilities will extend to improved treatment outcomes and 
quality of life to the end users. However, health facilities have few mechanisms established to 
minimise the challenges faced by patients accessing TB and HIV services (Sanou, Dembele, 
Theobald & Macq, 2004). Patients experience three layers of challenges in accessing TB-HIV 
integrated services. These include accessing the facility, regular attendance and experiences 
they had while in the health facility (Sanou, Dembele, Theobald & Macq, 2004). Moreover, 
pregnant women face a more complex situation as they contend with perinatal challenges and 
challenges associated with the dual infections of TB and HIV. Without adequate care, 
pregnant women co-infected with TB and HIV risk giving birth to co-infected babies with 
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resultant mortality and morbidity (Chintu & Mwaba, 2005). In this respect, integration of TB 
prevention and care into PMTCT program is paramount. Hence, the need for assessing the 
provision of TB/HIV/PMTCT services from patients’ perspective as well as to explore means 
of enhancing the delivery of TB/HIV/PMTCT integrated services and ultimately improve 
treatment outcomes. To date there are limited studies conducted to assess the provision of 
TB/HIV/PMTCT services from patients’ perspective particularly in rural areas with dual 
burden of TB and HIV. Hence the need for conducting this study in a rural district in 
KwaZulu Natal, namely Sisonke district. 
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CHAPTER 2  LITERATURE REVIEW 
2.1 Introduction 
This chapter reviews literature associated with the study, which  
• assessed whether patients actually got what they were supposed to get, and 
• what patients thought about the quality of care that they got, in integrated 
TB/HIV/PMTCT services in Sisonke District, KwaZulu Natal. 
 The literature review begins with the epidemiological, policy and programme foundations 
that led to the elements of integrated care assessed from patients’ perspectives in this study. It 
reviews the burden of TB and HIV epidemics worldwide, in sub- Saharan Africa and in South 
Africa, including the necessity for including PMTCT as a part of the provision of TB and HIV 
integrated care.  It outlines the policies, measures and strategies adopted to address the issues 
related to the implementation of the policy on collaborative TB/HIV activities from the 
upstream level and discuss the spill over effects to the individual end-users downstream. The 
focus is ultimately on the challenges faced by and the perspectives of the end users of TB and 
HIV integrated services including PMTCT (prevention of mother-to-child transmission). 
Finally, it reviews literature focusing on the perceptions of patients/clients on healthcare 
services in general. 
2.2.1 Global TB -HIV infection epidemiology 
HIV/AIDS and tuberculosis dominate the global burden of communicable diseases (Bonita, 
Beaglehole, & Kjellstrom, 2006).  When combined with HIV/AIDS, TB is a major contributor to 
the global burden of disease (Corbett, Marston, Churchyard & De Cock, 2006). The HIV 
pandemic interplays with TB epidemic by promoting disease progression and mortality among 
TB-HIV co-infected people (Lawn, Bekker, Middelkoop, Myer & Wood, 2006).  
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In the year 2007, there were 33.2 million HIV prevalent and 2.5 million HIV incident cases 
recorded globally (WHO, 2009b). Similarly, there were approximately 30.8 million adults and 
2.5 million children were living with HIV at the end of 2009 (UNAIDS, 2010). The HIV 
prevalence has resulted to increased incidence of TB (WHO, 2005). This situation made the 
World Health Organisation to declare TB as an emergency requiring immediate and 
extraordinary action in the African continent (WHO, 2005; Grimwood, Almeleh, Hausler, 
Hassan, 2006). 
TB is the commonest infectious agent for global human disability and mortality, since the history 
of man (Zumla, Malon & Henderson, 2001).  One-quarter of TB-caused deaths occurred in 
people living with HIV, as TB-HIV deaths was 456,000 in 2007 (WHO, 2009b). This situation 
has improved because of the progress made in scaling up ART provision with Africa accounting 
for 79% of the world’s 9.27 million incident TB cases, of which 1.37 million (14.8%) were HIV-
positive (WHO, 2009b). WHO (2009b) estimated that there were 13.7 million prevalent TB 
cases and 9.27 million new TB cases with 4.1 million (44%) cases of smear positivity in the year 
2007.  
2.2.2 TB and HIV epidemiology in South Africa 
In the recent past across sub-Saharan Africa as a whole, a quarter of HIV positive people had 
TB co-infection (De Cock & Chaisson, 1999). This TB and HIV co-infection poses various 
challenges in terms of resistance to drugs, diagnosis, treatment and burdens on the health 
system (Kassu, Mengistu, Ayele, Diro, Mekonnen et. al., 2007).  
South Africa has the highest number of people living with HIV/AIDS worldwide. The 
national antenatal clinic HIV prevalence was 30.2% in 2010 (National Department of Health, 
(2010).  
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Similarly, the WHO/UNAIDS model projects that the overall HIV prevalence in South Africa 
was 17.3% (UNAIDS, 2012)). This is still the highest in the world. South Africa had the worst 
TB-HIV co-infection prevalence rate worldwide. In2011, the figure was 768 per 100,000 
population. South Africa also had 650 incident rate per 100,000 population in 2011. South 
Africa also recorded 230 /100,000 TB-related deaths in 2007, ranking South Africa as the 
nation with the highest TB mortality rate in addition to higher cases of Multiple Drug 
Resistant TB (MDRT-TB) estimated to be 16,000 cases, including cases of extremely drug 
resistant TB (X-DRTB) (WHO, 2009). South Africa also accounts for an estimated 28% of 
the global populace living with TB-HIV co-infection (WHO, 2009b).  
2.2.3 TB and HIV epidemiology in Kwa Zulu Natal (KZN) 
TB-HIV co-infection rate in KZN is estimated at 80% in some settings (Gandhi et al, 2009). 
The HIV prevalence rate for KZN was 37.4% in the year 2007 (DOH, 2008). This figure has 
improved as the HIV prevalence among ANC clients tested was 28.3 (District Health 
Barometer, 2010). KZN’s HIV prevalence was 39.5% in the year 2010 (National Department 
of Health, 2010). Also in Sisonke district of KZN, the HIV testing rate for those attending 
antenatal clinic was 74.7% while the rate of HIV testing in the community was 2.6% (Sisonke 
District Report, 2006). There is a marked improvement in this figure as the proportion of 
antenatal care clients tested for HIV was 79.6 (District Health Barometer, 2010). Sisonke, a 
part of KZN has a HIV prevalence rate of 37.2% in 2010 according to antenatal survey 
(National Department of Health, 2010). Based on the recent WHO global progress report on 
TB, South Africa has been ranked as  country with the 3rd highest burden of TB (WHO 2009).  
KZN province is one of the provinces in South Africa with highest co-infection rate of TB and 
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HIV (UNAIDS, 2010). This has led to  the establishment of the TB Crisis Management Plan 
by the WHO/AFRO African Health Ministers (DOH, 2006). 
2.4 TB-HIV integration and PMTCT 
The epidemiological situation of TB and HIV epidemics in South Africa also encompasses 
PMTCT. PMTCT in South Africa forms part of the component of integrated care as 
HIV/AIDS is the leading cause of mortality amongst children of less than five years across all 
provinces of South Africa, because of the vertical transmission of HIV perinatally (Bradshaw, 
Nannan, Laubscher, Groenewald & Joubert, 2004). It is estimated that 40,000 children in 
South Africa get infected with HIV annually because of inadequate PMTCT measures. 
(Statistics South Africa, 2010). Despite the global improvements in perinatal mortality, 
around 30% of pregnant women in South Africa were HIV positive (National Antenatal 
Survey, 2009). This situation underscored the need for South Africa to deliver effective 
PMTCT programmes (DOH, 2010). To lessen the transmission of HIV to infant from HIV-
positive mothers especially through breastfeeding, PMTCT got prioritised in South Africa 
(HST, 2003).  PMTCT runs simultaneously with VCT and ARVs prophylaxis in public-
owned health facilities (HST, 2003). South Africa’s PMTCT programme aims to raise the 
general standard of PLWH mothers and protecting infants from being HIV infected (HST, 
2003). While South Africa’s PMTCT programme is breastfeeding-friendly, at the time of the 
study, it provided free infant feeding formula to mothers that opt to replace-feed their infants 
(DOH, 2007c). The relationship of PMTCT with TB-HIV integrated care addresses the gap 
associated with studies suggesting that children with TB-HIV co-infection have a 6-fold 
higher mortality rate in comparison to adults with related health conditions (Jeena, Pillay, 
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Pillay, Coovadia, 2002). Generally, TB is the commonest cause of morbidity and mortality in 
children co-infected with HIV (Chintu & Mwaba, 2005).  
Viewing the provision of TB-HIV and PMTCT integrated services from the clients’ point of 
view aims at ensuring that the integrated services enhance treatment outcomes (Sanou, 
Dembele, Theobald & Macq, 2004).  
 
Figure 1. South Africa’s National HIV prevalence 
 
Source: National Department of Health, (2010). 
 
2.5 Progress on the Implementation of collaborative TB/HIV activities worldwide 
2.5.1. Progress of implementation of collaborative TB/HIV activities in South Africa 
The objective of implementing collaborative TB and HIV activities according to the WHO is 
to lessen TB burden in HIV positive people and equally lessen the HIV burden in TB clients 
through provision on TB/HIV integrated care (WHO, 2004). The motivation for integrating 
TB and HIV activities is to ensure that TB-HIV co-infected clients receive optimal treatment 
and care.  
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2.5.2 The ProTEST initiative 
South Africa is an active participant in an initiative called ProTEST. ProTEST was initiated in 
1997 by WHO. It is an initiative established to stimulate a more articulate response to TB in 
areas with high HIV prevalence, through integrating TB and HIV control programmes, 
starting with HIV counselling / testing, and including a portfolio of prevention, care and 
support services (WHO, 2004). ProTESTs strategy is to lessen the burden of HIV-linked TB, 
with the merging of TB and HIV programmes (Faussett, Maher, Makadi, Nunn, Perriëns & 
Raviglione, 2002). The ProTEST initiative also enhanced the provision of TB-HIV and 
PMTCT integrated services in South Africa, with the establishment of TB/HIV pilot districts. 
These pilot districts executed and appraised a comprehensive TB/HIV prevention package that 
targeted pregnant women. The stakeholders, because of the TB-HIV Pilot Districts Initiative 
gained several levels of benefits. Amongst these benefits were home-based carers that 
received trainings on TB, with DOTS supporters trained on TB. Other benefits that resulted 
from the initiative were that TB-HIV clients started benefiting from an enhanced service as it 
relates to HIV care and the staffs of the health facilities were empowered to provide enhanced 
TB-HIV care, amongst others (Hausler, Similela, Vilakazi, Mvusi, Naidoo, Penrose et 
al.,2004).  Some of the lessons learned from the proTEST strategy include that there is: 
 a high demand of TB-HIV services with high degree of cross-referral between the two 
services; 
 a TB service targeting the attainment of an 85% cure rate amongst smear-positive 
patients; 
 a well-established and highly standardized TB service; 
 an HIV service with a more holistic approach to the patient with HIV; 
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The other side is that there are: 
 overlapping of activities; 
 staff under-utilisation. 
 TB-HIV-related services duplication; 
The result is that there are missed opportunities for TB and HIV prevention, diagnosis and 
management despite the benefits to integrating HIV and TB services (Coetzee, Hilderbrand, 
Goemaere, Matthys & Boelaert, 2004).  
Another lesson learnt was that it was possible to establish and sustain a successful integration of 
TB and HIV services in resource-constrained settings characterised by programmatic, 
infrastructural, and staffing challenges. This is to ensure that persons co-infected with TB and 
HIV are the beneficiaries of the best possible treatment outcomes involving the introduction of 
VCT,  Isoniasid preventive therapy and ART (Howard & El-Sadr, 2010). 
Based on the lessons learned from ProTEST study, the WHO developed an interim policy for 
collaborative TB/HIV activities as a policy guide for country to address the dual burden of TB 
and HIV from National, provincial, district and community levels. The policy was enacted 
globally, regionally and locally in support of integrative TB-HIV activities (Grimwood et al., 
2006). Figure 2 shows the links between TB and HIV activities, as outlined in the ProTEST 
work. Figure 2 depicts the opportunity of accessing TB and HIV integrated care through a 
range of related clinical services including sexually transmitted infection services for TB care. 
The figure also represents the range of accessible TB and HIV integrated care available for 
patients. They include psychosocial care; screening for HIV, TB & STIs, treatment and 
condom distribution. 
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Figure 2. Operationalising the link between TB and HIV activities 
 
Source: WHO / ProTEST, (2004). 
2.6 Progress of South Africa in implementing TB-HIV integrated activities in South 
Africa 
In consonance with WHO recommendations and the National Strategic Plans of South Africa, 
South Africa administers isoniazid preventive treatment (IPT) prior to starting other treatment 
regimens for TB-HIV co-infected people routinely, as studies elsewhere suggest that it is 
effective and economical (Foster, Godfrey-Faussett, & Porter 1997). Some of the progresses 
made in TB-HIV integrated activities in South Africa as reported by TB-HIV care (2011) 
include: 
 Strengthening of the link between communities and facilities via funded facility-based 
community team leaders coordinating community care workers.  
 Prioritisation of ART roll out in TB facilities; 
 Improved health systems management; 
 Implementation of policy changes that rationalise the us age of health facilities 
 Economical means of tracing TB contacts; 
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 Decentralisation of MDRTB treatment; 
 A comprehensive TB-HIV care, from diagnosis to treatment; 
In addition, there are efforts to scale up TB-HIV integrated activities throughout South Africa 
(WHO, 2009b). These efforts are geared towards improved case finding and overall improved 
treatment outcomes.   
2.7 The PMTCT linkage to TB-HIV integrated activities in South Africa 
Around the time of this study, children born with HIV in South Africa annually were around 
70,000, reflecting an inadequate PMTCT strategy against HIV/AIDS (WHO, 2009a). 
Exacerbated by the HIV epidemic, studies also show that there is a resurgence of TB amongst 
pregnant women (Margono, Mroueh, Garely, White, Duerr, et al., 1994). This scenario has 
made PMTCT strategic in TB-HIV collaboration, which in turn complements the National 
Strategic Plan (NSP) of South Africa on HIV/AIDS and STIs (DOH, 2007). In this context, 
the NSP, aimed at reducing the incidence rate of HIV in children below 5 years, through 
prevention of HIV infection, as well as providing treatment, care and support for eligible 
clients. From a global perspective, the National Strategic Plan of South Africa on HIV/AIDS 
and STIs complements international policies and guidelines on PMTCT (de Paoli. Manongi & 
Klepp, 2002). Similarly, South Africa’s revised PMTCT guidelines reflect the objectives of 
WHO recommendations.  According to the DOH (2010), the said PMTCT guidelines advise 
that: 
 all pregnant women that are HIV-positive should start receiving treatment at 14 weeks 
instead of in the last term of pregnancy; 
 HIV-positive pregnant women should start treatment when their CD4 count drops below 
350 cells/mm3; 
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 HIV-positive women should receive antiretroviral therapy postpartum. 
On a general note, the challenges related to access to TB, HIV and PMTCT services reflect other 
challenges earlier discussed above including those within the facilities like programmatic, 
infrastructural, and staffing challenges (Howard & El-Sadr, 2010). Other barriers occur both 
within the facilities and beyond. These are related to stigma and discrimination of those that are 
co-infected with TB and HIV (NACA, 2003). 
Figure 3. HIV prevalence amongst antenatal women in KZN by District, 2008 to 2010. 
 
Source: National Department of Health, (2010). 
 
 
2.8 Perception of patients on provision of TB/HIV/PMTCT integrated services  
2.8.1 Issues associated with implementing integrated TB/HIV activities and action 
taken to address these gaps 
Patients face a range of issues in accessing and adhering to TB/HIV services. These are 
outlined in Figure 4 below, and discussed in the following section. 
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Figure 4. Problem analysis diagram portraying challenges faced by clients of 
Tuberculosis and HIV integrated services including PMTCT. 
 
 
 
 
 
 
 
 
 
The provision of comprehensive care to people co-infected with HIV and TB is a general 
strategy of attending to these peoples’ needs by different disciplines ranging from medical 
care to social support (Narain, Chela & vanPraag, 2000). Clients’ choices in taking treatment 
are framed by the disease’s structural and psychological impacts and the society’s cultural 
systems (Tulsky, Hahn, Long, Chambers, Robertson et al., 2004). Inadequate human 
resources, poor health systems, insufficient clinical / laboratory infrastructure compound the 
situation in the face of TB-HIV co-infection, in addition to scant training programmes for 
integrated TB-HIV care (Corbett et al., 2006).  
The actions taken to address these gaps associated with the experiences of HIV positive 
people taking TB treatment or simultaneously undergoing treatment for both diseases include: 
Adverse effects of 
poverty, inclusive of 
constant hunger, 
trauma, etc 
Absence of proper 
monitoring of HIV and 
TB testing practices 
Inconvenient 
appointment times, 
long waiting periods 
and lack of privacy 
Inaccessible community 
health care workers outside 
the health facilities
Fear of agonising 
injections, etc. 
Interactions of TB 
and HIV drugs 
Low literacy levels 
Challenges faced by clients 
of tuberculosis / HIV joint 
activities 
Sociological issues 
revolving around stigma and 
discrimination workers 
Adverse experiences at the TB-
HIV health facilities, including 
attitude of clinicians  
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 Resolutions on how to implement HIV testing in TB patients by understanding issues 
surrounding HIV screening among TB patients as viewed from the local stakeholders' 
perspectives (WHO, 2005); 
 Studies on HIV testing in relation to other diseases exclusive of TB, which indicated 
that knowledge, fear and access might provide significant challenges to HIV testing (Lee, 
Cheung, Kwong, Wan & Lee 2005). 
2.8.2 Issues associated with TB-HIV integrated services at the national level 
Studies on this subject show that at the national level, there is underemployment of personnel, 
overlapping of activities and duplication of services for both TB and HIV (Coetzee et al., 
2004). Similarly, the ProTEST intervention’s lessons gathered from some pilot sites in South 
Africa reported that uptake of, and adherence to Isoniazid Preventive Therapy (IPT) was low 
after HIV counselling and testing. The low IPT adherence reflected on the proportion of 
patients completing 6 months of IPT ranging from 24% to 59% at the 6 pilot sites (WHO, 
2004). 
2.8.3 Strategies used to address the issues associated with TB-HIV integrated services at 
the national level 
The strategies used to remedy the situations included: 
o The introduction of the clinical record incorporating screening questionnaire at the 
Nelson Mandela Bay Clinic in Eastern Cape South, Africa. This led to a marked 
increase in the number of people coming for TB-HIV services. The purpose of 
introducing the clinical record was to check the bottlenecks associated with the tedious 
ritual of screening for TB every time the client attended follow-up care. This is 
constraining in facilities serving numerous people or in resource-constrained 
 
 
 
 
 
 
19
environments (Wessels, Verkuijl, Reed, et al.2009). This can affect the clients in the 
form of long waiting times and unprofessional treatment from the clinicians because of 
work pressure. 
o In the case of the ProTEST intervention’s issues discussed above, the report stated that 
addressing this gap involved: 
 encouraging clients to attend clinic support groups by the clients, 
 empathic and non-discriminatory clinic services by the clinicians, and 
 support from family members and the community.  
o o At a workplace HIV prevention and care program for miners, the intervention 
was successful as IPT uptake for eligible persons with HIV infection or AIDS that 
initiating IPT was successfully as high as 82%. On the other hand,, it was challenging 
to monitor treatment adherence (Charalambous, Grant, Day, et al., 2004). Factors that 
added to the intervention’s acceptability included: 
 attention paid to confidentiality issues, 
 efforts to minimise stigma, 
 the use of lay counsellors, 
Addressing the difficulties of monitoring treatment adherence involved connecting IPT 
implementation at the HIV care and treatment settings to routine TB case finding 
activities. 
2.9 Viewing TB-HIV integrated services from the perspective of the end users 
Adhering to integrated TB- HIV care relies on several psychosocial factors. A study (Daar, 
Cohen, Remien, Sherer & Smith, 2003) listed these psychosocial factors to include: 
 the knowledge of the clients of TB-HIV co-infection about the condition,  
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 rationale for adherence to TB-HIV integrated chemotherapy,  
 attitudes,  
 cultural / health beliefs,  
 coping skills,  
 level of motivation 
 confidence in the integrated therapy, and  
 confidence in the health care workers (HCWs)   
Related to this is that South Africans acquaintance with HCWs especially in terms of speaking 
the same language enhances adherence to drug regimens (Orell, Bangsberg, Badri & Wood, 
2003). This suggests that relative familiarity with the HCWs by the clients accessing TB-
HIV/PMTCT integrated services cushions the bottlenecks faced by these clients.  
Finally, clients of TB-HIV integrated services might encounter abuse of their rights within 
and outside TB-HIV integrated facilities (Office of the Premier, 2006). These rights of the 
clients include the rights to care, dignity, information, choice, confidentiality, justice and 
security (World Care Council, 2006). The strategy adopted to address rights-based issues 
involved proper monitoring of HIV and TB testing practice, which is essential to guarantee 
and enforce such rights-related policies in agreement with international guidelines on human 
rights and HIV/AIDS (Gruskin, 2004). The reason for this is that the rights of PLWHs are the 
same with the rights of others who are HIV negative. 
The discourse above indicates that the existence of cordial interpersonal relationships between 
patients of TB-HIV integrated care, the clinicians and the society is extremely vital to 
improved treatment outcomes. 
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2.10   Patients/clients perceptions on healthcare services 
Studies discussing patients’ perceptions of healthcare delivery seek to find out what their opinion 
is on the service they receive and viewing their general experience while accessing services in 
the health facilities from their perspective, rather than from the perspective of planners, 
researchers, or providers. Patients’ perceptions and anticipations are not simply linked because 
medical, clinical and health services are not technically inclusive (Priporas, Laspa and 
Kamenidou, 2008). Research accessed for this part of the literature review considers that 
healthcare services fall within the category of the service industry, and the field of services 
marketing. In recent years, there has been increased demand for better healthcare-based service 
delivery, because of continually evolving trends in societies’ demographics and psychographics 
(Daniels, 1993; Lamb, Hair, McDaniel, Boshoff & Terblanche, 2004). Healthcare providers 
strive to meet these changing trends of the patients’ needs and expectations by looking at the 
services they provide from the perceptions of these patients, who are increasingly more educated 
and informed about options and accordingly, more demanding (Grönroos, 2000).  
2.11 Findings on patients’ perceptions on healthcare services 
Studies suggest that the perceptions of patients on the quality of service they are likely to receive 
influence their degree of satisfaction positively, with resultant influences on the patient’s choice 
in choosing a specific healthcare provider (Andaleeb, 2001).  The plan of the healthcare industry 
is thus to ensure that these patients are satisfied with the services that they receive, as the 
industry considers that patient satisfaction is a key product of care (Lin and Kelly, 1995). 
Similarly, patient satisfaction boosts a health facility’s image, with a resultant increased service 
use and patronage (Andaleeb, 1988). While much of this healthcare industry research is based in 
developed countries, it is relevant to this study because there are differences in the way people 
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undergoing HIV therapy including those of TB-HIV integration view the services they receive. 
This affects their attitudes towards treatment adherence and eventually treatment outcomes 
(Davis-Michaud, Yurk , Lansky, Asch, & Wu, 2004). On the other hand, prioritising patients’ 
views makes it possible to address issues related to treatment defaults within and outside 
facilities offering TB-HIV integrated services and leads to improved treatment outcomes 
(Peltzer, 2009). 
As described by   Jackson,  Chamberlin & Kroenke, (2001), evaluating patient satisfaction serves 
several purposes related to improving health care. Some of these are: 
o to assess the quality of care 
o to identify which aspects of a service need to be modified to enhance patient satisfaction 
and  
o to assist health facilities in identifying beneficiaries that are likely to default or ‘disenroll’  
Another study found out that patient satisfaction with services received from health facilities 
depends on interpersonal relationship between the patient and the clinician like caring, empathy, 
reliability and responsiveness (Tucker, 2002). Furthermore, findings about patients perceptions 
on health services extends to other factors including core services provided at the health facilities 
like professional credibility, competence and communication skills on the part of the clinicians 
(Alrubaiee & Alkaa'ida, 2011). Generally human involvement in the service situation by the 
clinicians with display of empathy to the patient/client leads to positive patient outcomes such as 
pain relief, life saving and dealing with bitterness or disappointment with life after medical 
interventions (Bowers, Swan & Koehler, 1994). 
Patients’ perspectives on the provision of tuberculosis and HIV integrated services in Sisonke 
district, KwaZulu Natal therefore is an integral part of assessing healthcare service delivery in 
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relation to what the services are meant to provide, as well as addressing client satisfaction as 
described in the literature on patients’ perceptions of healthcare services. 
 
2.12 Research questions 
Based on the literature about TB/HIV integration, client satisfaction, and the importance of 
patient perspectives in assessing and improving services, this study asked a number of 
questions:  
i. How do the patients experience the provision of TB, HIV /PMTCT integrated care? 
ii. Do the patients’ perceptions on provision of TB/ HIV/ PMTCT care reflect what 
guidelines and the literature suggest should be provided at  facility level? 
iii. What are the constraints related to accessing TB/HIV/PMTCT services when viewed 
from patients’ perspectives? 
iv. What are the patients’ perspectives on the advantages of accessing integrated 
TB/HIV/PMTCT services? 
v. What are the patients’ perspectives on the desirability of community health workers 
support in the provision of TB/HIV/PMTCT care at community level? 
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2.13 Aim 
The aim of this study was to assess the provision of integrated TB/HIV/PMTCT services   
from patients’ perspectives. 
2.14 Objectives 
1. To explore patients’ perceptions on provision of TB/ HIV/ PMTCT care at the facility 
level.  
2. To identify constraints related to accessing TB/HIV/PMTCT services from patients’ 
perspectives. 
3. To understand patients’ perspectives on the desirability of provision of integrated 
TB/HIV/PMTCT services. 
4. To explore patients’ perspectives on the desirability of community health workers 
support in the provision of TB/HIV/PMTCT care at community level. 
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CHAPTER 3  METHODOLOGY 
3.1 Introduction 
This chapter discusses the research method for this secondary analysis as well as for the source 
study. This includes the study design, setting, population, sample size and procedure. It also 
discusses the data collection, processing, analysis, validity and reliability. Other topics discussed 
in this chapter are the study’s generalisability, limitations and ethical considerations.  
This study relies on a secondary analysis of data earlier collected from a larger ongoing project 
conducted in Sisonke district on TB and HIV integrated activities including PMTCT. The data 
was collected using exit interviews with patients accessing    TB, HIV (pre-ART and ART) and 
PMTCT services in 10 selected facilities. This study   reports on the analysis of  interview data, 
conducted by the researcher. 
3.2 Source Study and project study design 
This study used a cross-sectional exploratory survey design. The use of the cross-sectional 
design was adopted because it was convenient and cost-effective for an exploratory study. The 
survey took in Sisonke district, KwaZulu Natal from August to September 2008. The overall 
research method used for this study consisted of a mixed methods research approach using 
both quantitative and qualitative methods.  A mixed methods research approach as defined by 
Onwuegbuzie & Leech (2006) is a third research method paradigm that makes use of both 
quantitative and qualitative methods concurrently or sequentially. An ideal mixed methods 
study integrates the research objectives with both qualitative and quantitative approaches and 
methods (Tashakkori & Creswell, 2007;  Johnson & Onwuegbuzie, 2004). The mixed 
methods research method enhances quantitative-based research outcomes as the collection, 
analysis, and interpretation of qualitative data can aid the interpretation of statistically and 
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practically significant findings. In the same vein, quantitative data collection, analysis and 
interpretation add more meaning to qualitative findings, hence the choice of mixed methods 
research. As it relates to this study, the use of mixed methods research is to ensure that the 
findings are exhaustive. 
The instruments used for the exit interviews consisted of both closed and open ended 
question. The open ended questions were referring to perception on provision of and 
challenges related to provision of integrated TB/HIV/PMTCT services while closed ended 
questions were referring to kind of services TB, HIV and PMTCT patients received on the day 
of the visit at the facility. While the analysis is mostly quantitative, open ended questions were 
analysed qualitative by identifying categories and themes, then analysed quantitatively. The 
present sub-study focus more on quantitative analysis rather than a full mixed-methods study.     
3.3 Study setting 
Sisonke District in KZN Province, South Africa was the site of the research. KZN is among 
the five provinces of South Africa with the highest TB-HIV co-infection rates (UNAIDS, 
2008).  Sisonke district has a geographic area of 11,128 km2, divided into five municipalities. 
These include Greater Kokstad, Ingwe, KwaSani, Ubuhlebezwe and UMzimkhulu. With a 
population of 500,000, the district has 13.6% urbanisation, 79% unemployment and 71% 
poverty rates (Sisonke District Report, 2008). The literacy level is low with farming as the 
predominant occupation. The district is poor in infrastructure with understaffed and poorly 
equipped community health centres. The setting is characterised by poor transportation 
systems with attendant restricted access to health facilities. Government-run health facilities 
and some Non Governmental Organisations (NGOs) provide community and home based TB 
and HIV services activities in Sisonke.  
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TB/HIV Care Association is one of the NGOs providing support to the provincial Ministry of 
Health in Sisonke and has been supporting provision and integration of TB/HIV/PMTCT 
services in selected facilities across the district since 2007. All of the facilities where data 
collection took place for this study were supported by TB/HIV Care Association. The ten 
facilities were purposively selected at sub-district level by considering the three levels of care 
and the existence of an antiretroviral treatment clinic at the three levels of care.  
Hence, a total of 4 district hospitals, 1 Community Health Centre and 4 Primary Health Care 
clinics were selected out of the 45 facilities in the district. 
3.4 Study population 
The study was conducted from August-September 2008. The study population comprised of 
antenatal-PMTCT and HIV (pre-ART & ART) and TB patients attending the 10 selected 
facilities in the district as contained in Appendix 1. The inclusion criteria included all registered 
TB, HIV and PMTCT clients between the period of January-June 2008 attending the selected 
facilities aged 18 years and above..  
3.5 Sample size and sampling procedure 
The sample size was calculated based on the number of respondents that could be interviewed 
by field workers. Based on the pilot of the questionnaire, one field worker could interview up 
to 18 clients on a day. The maximum number of clients that could be interviewed by two field 
workers in ten facilities over 20 days yielded a sample of 360 clients. The numbers of clients 
for each category was drawn proportionately from the total number of registered clients from 
January –June 2008 in each facility. Each facility had a quota of clients to interview as 
illustrated in appendix I. The sample size was not intended to be statistically generalizable to 
all patients, but to capture a broad range of perspectives that were likely to reflect a substantial 
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part of the overall experience of the TB,HIV and PMTCT clients attending the selected 
facilities. 
3.6 Sampling strategy and procedure 
The sampling frame used at district level consisted of a selection of facilities based on the 
level of care (i.e. district hospital, Community health centre and PHC clinic) and the existence 
of an antiretroviral therapy clinic at each level of care. The sampling frame used at patient 
level was based on all PMTCT, HIV and TB patients registered  at the 10 selected facilities 
between January-June 2008 aged 18 years and above as illustrated in  Appendix I.  
The facilities were selected purposively based on the criterion listed above and a convenience 
sample of 360 patients was drawn proportionately   from the total number of registered clients 
of each category (i.e. ANC-PMTCT, HIV and TB) in 10 selected facilities. The actual 
selection of individual study participants followed a systematic sampling approach. 
Systematic sampling considers selecting elements from an ordered sampling frame. 
Systematic sample units are consistently distributed over the population provided the said 
population is logically homogeneous. The feature of this approach is that it gives every 
element of the population under study a known and equal probability of selection in an 
ordered sampling frame (Black, 2004). An ideally random sampling that is representative of 
the general population is not usually possible within a clinical environment except if there are 
other sources of ensuring that the clinic population is truly representative of the general 
population. Ensuring true representativeness is therefore usually unrealisable, though it is 
possible to get a properly representative random sample of the population of patients who 
have access to, and use these facilities. This adds to the choice of adopting systematic 
sampling to minimise such gaps. The advantage of using systematic sampling is that it is easy, 
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quick and less expensive. In this scenario, it is necessary to select a part of the general 
population under study (Denise, Cheryl, & Hungler, 2001). A systematic sampling approach 
was used whereby at each point of service every second client exiting the consultation room 
was approached for the interview. Hence, the recruitment of the respondents was done on a 
daily basis, based on their attendance at the facilities. 
3.7 Data collection and processing 
The data collection method used in this study consisted of an exit interview using a 
questionnaire.   Trained data collectors interviewed the respondents as they were leaving the 
consulting rooms of the health workers at the TB/HIV/PMTCT units in the facilities. 
Invitation of these respondents to participate in the study was followed by requesting 
individual informed consent from the respondents before the interview. Participants’ 
information sheet and informed consent forms are included in Appendix II and III.   
The questionnaire was designed in English by the principal investigator of the project. A 
professional translator translated this into isiZulu language and back again into English.  The 
content of the questionnaire elicited the following information: 
o the services provided by the healthcare worker (HCW)on the day the visit to the health 
facility; 
o challenges faced by the respondents in accessing TB, HIV and ANC-PMTCT services; 
o opinion of the respondents on the involvement of  community health workers (CHWs) 
in providing TB/HIV/PMTCT services at  household level. 
The questionnaires used in the study are in appendices IV  and V respectively. 
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3.8 Data analysis 
This study reports on a secondary analysis of data earlier collected from a larger ongoing 
project conducted in Sisonke district on integration of TB and HIV programmes including 
PMTCT.  First, the data were checked to ensure completeness and internal consistency. The 
quantitative data was stratified, with subsequent cleaning and coding for analysis. The coding 
of the answers depended on the nature of the responses to the questions, which were either 
ordinal or nominal. Coding the questions with multiple responses according to the frequency 
of the responses took place. In this regard, it involved number-assignment of the commonest 
responses while other less common responses were clustered. The close-ended questions were 
classified as binary variables. These are: 
o sex – female / male; 
o age - 18-30 years / 31 years or older;  
o respondents category -  PMTCT / pre-ART & ART / TB. 
o Other close-ended questions included 'Education about CD4 test', 'Underwent CD4 
test', 'Education about ARVs', 'Education on adherence Support', 'Education about TB', 
choice of location of  TB/HIV/PMTCT services facility, choice of provision of 
TB/HIV/PMTCT services by the same or different clinician and option of home visit 
by a community health care worker. 
The responses contained in the qualitative part of the questionnaire used for the study were 
reviewed repeatedly and clustered into major subgroups prior to assigning a name to each of 
the emerging broad themes. These theme keywords were then used   cluster comparable 
responses into subcategories by checking whether the theme keyword adequately captured 
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each response. These clustered responses were subjected to extra assessment and 
consideration, looking for subthemes and subcategories within the major subgroups. 
 The responses that appeared to cluster together under a subtheme were  compiled to form a 
common category. The resultant categories were also inspected for similarities before 
compiling a final shortlist of comparatively mutually exclusive categories. This process of 
reviewing, coding and grouping responses into thematic categories and subcategories was the 
qualitative part of the analysis. Each of these was coded with a keyword label, and the 
numbers of responses per keyword were analysed quantitatively along with the responses to 
the closed-ended questions.   The Statistical Package for Social Sciences (SPSS) version 19 
was used to capture and analyse the data using descriptive statistics. The measures of central 
tendency such as frequency, means, median and standard deviation were used for continuous 
data while categorical data were analysed using frequency and proportions. A Chi-square test 
was used to   assess the association between depend and independent variables. A Chi-square 
test with a p-value of 0.05 was considered as statistically significant.  
3.9 Validity 
The extent to which an instrument measures what it originally aims to measure is validity 
(Denise, Cheryl, & Hungler, 2001). isiZulu is the main language spoken in Sisonke, a 
professional translator from Medical Research Centre (Durban Centre) translated the 
questionnaires from English to isiZulu and re-translation of the questionnaires from isiZulu 
back to English in order to ensure validity there after. A pilot study was conducted to ascertain 
if the respondents easily understood the contents of the questionnaire and if these questions 
were clear and unambiguous. Based on the results of the pilot, the questionnaire was modified 
accordingly. 
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3.10 Reliability 
Reliability implies the extent or degree of similarity of information got with the repetition of 
the study or measurement in question on the same respondents. It considers if the information 
will be the same or will change anytime it is measured and the extent to which such 
information will change (Katzenellenbogen, Joubert & Abdool Karim, 1997).  
The same sets of questionnaires were used in all the health facilities or clinics during the data 
collection. All the subparts of the questionnaires had the same measurements using similar 
characteristics. For uniformity and consistency especially with respect to antenatal-PMTCT 
clients as well as HIV and TB clients most of the questions were similar with the exception of 
some as indicated in appendices 4 and 5. The fieldworkers were trained and were supervised 
during the collection of data. The analysis of these data was done by the researcher with 
support from a statistician and from the supervisors.  
3.11 Generalisability 
Generalisability implies that the sample taken for the study can be generalised for the whole 
population. In quantitative research, generalizability usually means statistical generalizability, 
which requires a random sample and that other statistical assumptions are met. Because this 
was not a random sample of the facilities or the whole population, the study results are not 
statistically generalizable. However because the sample was quite large and was purposively 
selected to capture a wide range of facilities and programmes across the whole district, it is 
probably a good reflection of what is going on across the facilities supported by TB/HIV Care 
Association and, in respect of general constraints and views on accessing care, is probably 
generalizable to the population of the district. This study asked about experiences and 
perceptions on services provided by particular programmes and facilities and reflects the 
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services actually provided. Therefore the results are not generalizable to other facilities, where 
services may be better or worse or different. However this study, especially when added to the 
findings of other parts of the Source study, can be said to be relevant for theoretical 
generalisability – its findings can help to interpret and be applied to similar questions in 
similar settings.    
3.12 Limitations for this study 
This study is not free of limitation. The fact that the researcher did not participate in the 
design and data collection poses a limitation as it restricts the researcher from probing deeper 
into the responses given by the respondents, with the possibility of biases being introduced 
into the study. Another study limitation is that data on services received are based on patients’ 
self reports, rather than direct observation of patient-provider encounters or medical record 
data. This could bias results in either direction. Patients could under-report because they 
forgot (recall bias) or did not understand, or they could over-report because of social 
desirability bias.  
3.13 Ethical considerations 
The researcher sought permission from the custodian/owner (primary researcher) of the data. 
The researcher also adhered to maintaining data integrity including the confidentiality 
procedures as defined in the primary study. As this is an integrated study, the primary 
researcher earlier sought ethical clearance of the project. The letter of the approval of the 
major project/study is as contained in Appendix 8. Other activities executed by the primary 
researchers include that the ethical clearance for “Community participation in tuberculosis and 
HIV integrated activities, constraints and costs for enhancing the integration of tuberculosis 
and HIV programmes in a rural area of South Africa”, project number: CHHD 08-4 14 March 
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2008, was obtained  from the Ethics Committee of the University of the Western Cape.  The 
consent form and information sheets used in this project are appendices 6 and 7 respectively 
hereunder. In addition, the KZN Department of Health (Research unit), the District Manager 
of Sisonke and the facility managers of the selected health facilities gave permission for the 
study to take place. In order to maintain anonymity, there were no records taken of any 
participant’s name on the questionnaires. The informed consent and interviews were in the 
preferred language of the participant either in English or in isiZulu. The information sheet 
approved by the Ethics Committee was translated into isiZulu. All participants were free to 
withdraw at any point devoid of any adverse consequences, even after granting their prior 
consent to the interviewers. In addition to that, confidentiality was maintained throughout the 
study. 
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CHAPTER 4  RESULTS 
4.1 Introduction 
This chapter presents the findings of this study based on the study questions and objectives.  
The findings are categorised into three divisions comprising PMTCT Clients; TB clients and 
HIV or pre-ART & ART clients. These pre-ART & ART clients consist of those that are 
about to start receiving antiretroviral therapy (pre-ART) and those already receiving 
antiretroviral therapy (ART). The reason for differentiating between the respondents is that in 
these TB-HIV integrated clinics or facilities, the access point for some of the clients is via 
PMTCT clinics. Others access treatment as (antiretroviral therapy) ART clients while others 
undergo therapy as TB clients. The differentiation will enable the study to determine whether 
clients accessing TB-HIV services through these three different gateways have different 
experiences of provision of integrated care. The response rate was 76% (274 out of 360).  Out 
of the 360 clients recruited, 274 clients agreed to be interviewed during the data collection 
period and this gave a response rate of 76%. 
4.2.1 Demographic characteristics of the respondents 
The demographic characteristics of the respondents included gender and age. As presented in 
Table 4.1 below, all PMTCT clients are of course women; however women were also the 
majority of both HIV and TB clients, with the TB clients coming closest to an equal gender 
distribution. On the average, the PMTCT respondents were younger than the HIV and TB 
respondents were. Similarly, looking at the CD4 count results, the table suggests that PMTCT 
clients are the healthiest, while the TB and HIV clients are sicker. The median CD4 counts are 
high for the PMTCT programme and comparatively low for the HIV and TB programmes, 
which suggest that many clients are still accessing TB/HIV/PMTCT integrated care late, when 
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they are quite sick but that some are doing very well on treatment. It can be suggested that 
these CD4 counts are much better than what was obtainable a few years ago, when single and 
double digit counts were extremely common. 
Table 4.1 Demographic characteristics and the CD4 count of the respondents 
 Patients category 
Characteristics PMTCT HIV (ART & pre 
ART) 
TB 
Age    
Mean 25.9 36.9 36.7 
SD 5.9 10.5 11.5 
Range (Age)    
Lowest 18 19 18 
Highest 46 75 70 
CD4 Count    
Median 298.5 177 94 
25 198.75 94.00 54.00 
50 298.50 177.00 94.00 
Percentiles 
(IQR) 
 75 467.45 341.00 171.00 
Gender N (%)    
Female 137 (100) 95 (77.9) 31 (46.3) 
Male 0 (0.0) 19.6 (22.1) 36 (53.7) 
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4.2.2 Distribution of participants by age groups 
The ages of the respondents were divided into two groups, as preliminary analysis with a 
larger number of age categories yielded cell sizes that were too small to analyse. The age 
groups chosen were: 
o 18-30 years 
o > 30 years (consisted of those that were 31 years old and older) 
This classification was chosen because it was felt that differences in treatment experience and 
perceptions around the study questions would probably be different for younger adults (18-30) 
than for older adults, over 30 years, who have different overall roles and status in the 
community.  
The PMTCT category consisted of 105 (76.6%) respondents aged 18-30 years and 32 (23.4%) 
respondents aged > 30 years. The pre-ART & ART respondents consisted of 36 (29.5%) 
respondents aged 18-30 years and 86 (70.5%) respondents aged > 30 years. The TB category 
consisted of 22 (32.8%) respondents aged 18-30 years and 45 (67.2%) respondents aged > 30 
years. The older respondents outnumbered the younger ones, but for the PMTCT programme. 
See table 4.1 for details of the age groups.  
4.3 Themes and codes emerging from qualitative questions 
Before analysing the distribution of the answers to the open-ended questions, responses were 
read, re-read, and clustered into major and minor thematic groups. These are presented below, 
with the total frequency counts of the final code keywords. Details of these are as contained in 
tables 4.2 to 4.5 below. Responses that occurred twice or less than two times were coded as 
“other” and reflected diverse reasons, individual personal concerns and issues. While many 
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responses clustered in themes, there was considerable individual variability. While some of the 
“Other”/individual reasons were somewhat related to the major themes, they were left as “other” 
in order to avoid imposing homogeneity on a diverse issue. 
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Table 4.2 Advantages of having services for TB and HIV in the same clinic 
Category of Respondents 
PMTCT HIV TB 
 
 
N ( %) N ( %) N ( %) 
1 Accessibility 40 17.6 42 23.2 29 27.9
2 Ensure Privacy/confidentiality 57 25.1 68 37.6 37 35.6
3 Save money/ Minimise transport costs 41 18.1 29 16.0 14 13.5
4 Time saving 58 25.6 29 16.0 15 14.4
5 Reduce stigma 3 1.3 1 .6 9 8.7
6 Diverse features/Other 28 12.3 12 6.6 29 27.9
 
Table 4.3 Disadvantages of having services for TB and HIV in the same place 
Category of Respondents 
PMTCT HIV TB 
 
 
N ( %) N ( %) N ( %) 
1 Lack of privacy 17 41.5 8 44.4 0 0.00
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2 Enhance stigma 6 14.6 0 0.00 0 0.00
3 Poor care given/non-comprehensive care 8 19.5 9 50.0 0 0.00
4 Lost in referral process 10 24.4 1 5.6 1 100
5 Lack of privacy 17 41.5 0 0.00 0 0.00
6 Other disadvantages / other 0 0.00 0 0.00 0 0.00
 
Table 4.4 Obstacles associated with TB/HIV/PMTCT Integrated services 
Category of Respondents 
PMTCT HIV TB 
 
 
N ( %) N ( %) N ( %) 
1 Inconvenient 53 39.3 59 51.8 12 17.6
2 Enhance stigma 16 11.9 8 7.0 6 8.8
3 Poor care given/non-comprehensive care 19 14.1 9 7.9 1 1.5
4 Lost in referral process 22 16.3 0 0.00 18 26.5
5 Not getting medication on time/defaulting 23 17.0 21 18.4 31 45.6
6 Assorted personal issues / other 2 1.5 17 14.9 0 0.00
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4.4 Summary of the findings 
The following tables hereunder present the summary results of the descriptive analysis, 
disaggregated by the programme of access (PMTCT, HIV, and TB).  The first few rows up to 
“education on adherence support” document patients’ reports on whether or not they received 
key elements of integrated TB/HIV care. The remaining items document what patients report 
as the advantages, disadvantages, challenges and preferences regarding accessing integrated 
services.  
4.4.1 Analysis of patients’ perspectives by gender and age in the three programmes 
This is a presentation of a combination of the descriptive results involving who reported 
receiving what services and expressing what perspectives), as well as analyses comparing age 
and gender groups across the 3 categories of programme. Also, the result suggests that there 
appears to be differences and trends, but that on the whole these are not statistically significant. 
4.4.1.1 Comparing responses between younger and older clients 
The result suggests that a majority of the respondents across the three categories were educated 
about the necessity of CD4 testing. While a greater proportion of younger respondents reported 
so in the PMTCT category, the older respondents did in the HIV and TB categories respectively. 
The trend continued in their reportages about undergoing CD4 testing, education about ARVs, 
education about TB, adherence support. In terms of the advantages, disadvantages and barriers to 
accessing TB/HIV/PMTCT integrated services, there seemed to be a proportionate distribution in 
the responses amongst the three categories though the younger respondents comparatively take 
the lead in reporting about their experiences in accessing TB/HIV/PMTCT integrated services. 
All the p-values suggest that the individual results across the three categories were 
predominantly not statistically significant. That is to say that 'Education about CD4 test', 
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'Underwent CD4 test', 'Education about ARVs', 'Education on adherence Support', 'Education 
about TB', 'Advantages/positive experiences reported', 'Disadvantages/negative experiences' and 
'Challenges to access' were all not statistically significant and associated with the age groups of 
the respondents. 
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Table 4.5.1.1 Analysis of patients’ perspectives on TB and HIV services provided with age group in the three programmes 
  PMTCT Category HIV (ART & pre ART Category) TB Category 
18 to 30 
year-olds 
> 30 years 
p-
value 
18 to 30 
year-olds 
> 30 years 
p-
value 
18 to 30 
year-olds 
> 30 years 
p-
value Variable Response 
n % n % n % n % n % n %
Yes 25 67.6 12 32.4 35 29.2 85 70.8 13 32.5 27 67.5Education 
about CD4 test No 0 0 0 0 1 50.1 1 50.1
.505
0 0 2 100
1.000
Yes 21 63.6 12 36.4 35 29.9 82 70.1 12 31.6 26 68.4Underwent 
CD4 test No 4 100 0 0
0.282
1 20.0 4 80.0
1.000
1 25.0 3 75.0
1.000
Yes 24 66.7 12 33.3 34 29.8 80 70.2 12 30.8 27 69.2Education 
about ARVs No 1 100 0 0
1.000
2 25.0 6 75.0
1.000
1 100 0 0
0.325
Yes 17 65.4 9 34.6 20 25.0 60 75.0 9 31.0 20 69.0Education on 
adherence 
Support 
No 
8 72.7 3 27.3
1.000
16 38.1 26 61.9
0.148
4 40.0 6 60.0
0.704
Yes 75 74.3 26 25.7 30 28.9 74 71.2 6 23.1 20 76.9Education 
about TB No 30 83.3 6 16.7
0.360
6 33.3 12 66.7
0.781
6 42.9 8 57.1
0.281
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Table 4.5.1.2 Analysis of advantages and disadvantages of services provided with age group in the three programmes 
  PMTCT Category HIV (ART & pre ART Category) TB Category 
18 to 30 
year-olds 
> 30 years 
p-
value 
18 to 30 
year-olds 
> 30 years 
p-
value 
18 to 30 
year-olds 
> 30 years 
p-
value Response 
n % n % n % n % n % n %
Variable 
No 30 83.3 6 16.7 6 33.3 12 66.7 6 42.9 8 57.1
Accessibility 26 65.0 14 35.0 18 42.9 24 57.1 10 45.5 19 46.3
Ensure 
Privacy/conf
identiality 
43 75.4 14 24.6 15 22.1 53 77.9 11 50.0 26 63.4
Save money/ 
Minimise 
transport 
costs 
30 73.2 11 26.8 8 27.6 21 72.4 5 22.7 9 22.0
Advantages/po
sitive 
experiences 
reported  
 
Time-saving 48 82.8 10 17.2
0.221
10 34.5 19 65.5
.209
6 27.3 9 22.0
0.463
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Reduce 
stigma 
2 66.7 1 33.3 0 .0 1 
100.
0
0 0 0 0
Diverse 
features 
22 78.6 6 21.4 2 16.7 10 83.3 2 9.1 7 17.1
Lack of 
privacy 
14 82.4 3 17.6 4 50.0 4 50.0 0 0 0 0
Enhance 
stigma 
6 100 0 0 0 0 0 0 0 0 0 0
Poor care 
given/non-
comprehensi
ve care 
7 87.5 1 12.5 1 11.1 8 88.9 0 0 0 0
Disadvantages/
negative 
experiences 
Lost in 
referral 
process 
8 80.0 2 20.0
0.458
1 100 0 0.00
.107
1 100 0 0
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Table 4.5.1.3 Analysis of challenges associated with providing TB-HIV integrated services with age group in the three programmes 
  PMTCT Category HIV (ART & pre ART Category) TB Category 
18 to 30 
year-olds 
> 30 years 
p-
value 
18 to 30 
year-olds 
> 30 years 
p-
value 
18 to 30 
year-olds 
> 30 years 
p-
value Variable Response 
n % n % n % n % n % n %
Inconvenient 43 81.1 10 18.9 23 39.0 36 61.0 2 11.8 9 23.7
Enhance 
stigma 
13 81.3 3 18.8 2 25.0 6 75.0 0 .0 5 13.2
Poor care 
given/non-
comprehensi
ve care 
16 84.2 3 15.8 3 33.3 6 66.7 1 5.9 0 .0
Lost in 
referral 
process 
15 68.2 7 31.8 0 0 0 0 8 47.1 10 26.3
Challenges to 
access 
Not getting 
19 82.6 4 17.4
0.955
6 28.6 15 71.4
.578
10 58.8 21 55.3
0.222
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medication 
on 
time/defaulti
ng 
Assorted 
personal 
issues 
1 50.0 1 50.0 3 17.6 14 82.4 0 0 0 0
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The assorted personal issues as presented in Table 4.5.1.3 above are presented hereunder as 
reported verbatim by the respondents are as presented in table  4.5.2.1 below. 
 
Table 4.5.2.1 Assorted personal issues or difficulties associated with accessing 
TB/HIV/PMTCT Integrated services 
Bad service 
Be on labour 
Confusion 
Delay 
Different queues 
Disclosing to different people 
Distance 
Far 
Fear 
Files will get mixed up 
Hungry 
I like getting my treatment in one place, going to different facilities will inconvenient me 
I'm working 
Insufficient medication 
It will be intimidating  
Its strenuous when you're ill 
Lack of facilities in the nearest clinic 
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Laziness  
Lazy 
Long distance  
Long queues 
Lost 
Male   
Medical records in different places 
Might not receive treatment in time 
Money   
No difficulties if the appointment dates are separate 
Not Cared for 
Not recognized 
Nurses might not be there 
Queues  
Risk of getting ARV treatment in time  
Risk of not getting your treatment in time 
Senior professional; nurse not available 
Service  
Stigma 
Swollen feet 
The new people might be unfriendly to you 
The risk of not receiving your treatment in time   
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The risk of not taking medication in time 
They might conceive on the way   
They will need details all the time 
Time  
Timid 
Tiring   
Transport 
Walking   
Weather conditions 
Won’t make it to different appointment 
Won't make it to TB clinic  
Work 
Your condition will worsen because of the delays in taking your treatment 
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4.5.1.1.2 Choice of clinician and location of TB/HIV/PMTCT integrated services from the age 
group angle 
The result suggests that a greater proportion (> 50 %) of the respondents preferred different 
clinicians. However, the younger respondents in the PMTCT category (82.7%) preferred the 
same clinician unlike the younger respondents of the HIV (26.3%) and TB (44.4%) categories. 
Most of the respondents reported that they preferred TB/HIV/PMTCT facilities to be located in 
the same place. All the p-values imply that the individual results across the three categories were 
not statistically significant. 
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Table 4.5.3 Perception on preferences on provision of TB/HIV/PMTCT integrated services from the age group angle 
  PMTCT Category HIV (ART & pre ART Category) TB Category 
18 to 30 year-
olds 
> 30 years 
p-
value 
18 to 30 year-
olds 
> 30 years p-value 
18 to 30 
year-olds 
> 30 years 
p-
value Variable Response 
n % n % n % n % n % n %
Same 43 82.7 9 17.3 10 26.3 28 73.7 12 44.4 15 55.6Choice 
of 
clinician 
Different 
62 72.9 23 27.1
0.217
26 31.0 58 69.0 
.672
10 25.6 29 74.4
0.122
Same 95 75.4 31 24.6 33 29.2 80 70.8 22 33.3 44 66.7Choice 
of 
location 
Different 
10 90.9 1 9.1
0.457
3 33.3 6 66.7 
0.722
0 0 1 100
1.000
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4.5.1.1.3 Choice of community health workers support in providing TB/HIV/PMTCT integrated 
services from the age group angle 
 Table 4.5.4 below illustrates that many (43.7%) of the respondents preferred community health 
workers (CHW) assistance in continuation of TB/HIV/PMTCT integrated services beyond the 
facilities. A majority (67.7%) of younger clients in the PMTCT category wanted CHWs support 
while a greater proportion of HIV and TB respondents preferred CHWs support. All the p-values 
suggest that the individual results across the three categories were not statistically significant. 
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Table 4.5.4 Choice of community health workers support in providing TB/HIV/PMTCT integrated services from the age group angle 
  PMTCT Category HIV (ART & pre ART Category) TB Category 
18 to 30 
year-olds 
> 30 years 
p-
value 
18 to 30 year-
olds 
> 30 years 
p-
value 
18 to 30 
year-olds 
> 30 years 
p-
value Variable Response 
n % n % n % n % n % n %
Yes 21 67.7 10 32.3 31 30.1 72 69.9 12 33.3 24 66.7Desire for 
community 
health workers 
support 
No 
0 0 1 100
0.344
1 33.3 2 66.7 
1.000
0 0 3 100
0.539
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4.5.1.2 Provision of TB and HIV services based on gender 
Considering the provision of TB and HIV services based on the respondents’ gender, the 
findings of the study indicate that a significant proportion of female HIV (pre ART & ART) 
(94.7%) of respondents and all (100%) female TB respondents reported on being provided 
services on HIV, especially on the provision of ARVs. Similarly, most female ART & pre ART 
respondents (83.2%) and female (72.2%) of TB respondents also reported that they received 
education related to the provision of TB services in the facilities. The trend continued in their 
reportages about undergoing CD4 testing, education about ARVs, education about TB, 
adherence support.  
Most of the p-values, except for cross tabulating ‘Education on adherence Support’ with gender 
for the TB category suggest that the individual results across the three categories of respondents 
were not statistically significant. That is to say that 'Education about CD4 test', 'Underwent CD4 
test', and 'Education about ARVs 'Education about TB', were all not statistically significant and 
associated with the gender of the respondents. 
 
 
 
 
 
 
56
Table 4.5.5.1 Analysis of patients’ perspectives on TB and HIV services provided with gender in the three programmes 
  HIV (ART & pre ART Category) TB Category 
Females Males 
p-
value 
Females Males p-value 
Variable Response 
n % n % n % n %
Yes 93 97.9 27 100.0 18 94.7 22 95.7Education about CD4 
test No 2 2.1 0 .0
1.000
1 5.3 1 4.3
1.000
Yes 91 95.8 26 96.3 18 94.7 20 87.0Underwent CD4 test 
No 4 4.2 1 3.7
1.000
1 5.3 3 13.0
0.613
Yes 90 94.7 24 88.9 19 100.0 20 95.2Education about 
ARVs No 5 5.3 3 11.1
0.373
0 .0 1 4.8
1.000
Yes 60 63.2 20 74.1 17 94.4 12 57.1Education on 
adherence Support No 35 36.8 7 25.9
0.362
1 5.6 9 42.9
0.011
Yes 79 83.2 25 92.6 13 72.2 13 59.1Education about TB 
No 16 16.8 2 7.4
0.357
5 27.8 9 40.9
0.510
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The advantages and disadvantages to accessing TB/HIV integrated services, as presented in table 
4.5.5.2 hereunder suggests there was a proportionate distribution in the responses amongst the 
two categories though the female respondents comparatively take the lead in reporting about 
their experiences in accessing TB/HIV integrated services.   
'Advantages/positive experiences reported' and 'Disadvantages/negative experiences' were all not 
statistically significant and associated with the gender of the respondents. 
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Table 4.5.5.2 Analysis of advantages and disadvantages of services provided with gender in the three programmes 
  HIV (ART & pre ART Category) TB Category 
Females Males 
p-
value 
Females Males p-value 
Variable Response 
n % N % n % n %
Accessibility 37 42.0 5 20.0 10 45.5 19 46.3
Ensure 
Privacy/confidenti
ality 
52 59.1 16 64.0 11 50.0 26 63.4
Save money/ 
Minimise transport 
costs 
20 22.7 9 36.0 5 22.7 9 22.0
Time-saving 24 27.3 5 20.0  
Reduce stigma 1 1.1 0 .0 0 0 0 0
Advantages/positive 
experiences reported  
 
Diverse features 6 6.8 6 24.0
0.242
6 27.3 9 22.0
0.903
Disadvantages/negati Lack of privacy 8 57.1 0 .0 0.198 0 0 0 0
 
 
 
 
 
 
59
Poor care 
given/non-
comprehensive 
care 
6 42.9 3 100.0 0 0 0 0
ve experiences 
Lost in referral 
process 
1 7.1 0 .0 1 100 0 0
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As presented in Table 4.5.5.3 under, there was a proportionate distribution in the responses 
amongst the two categories though the female respondents comparatively take the lead in 
reporting about their experiences in accessing TB/HIV integrated services as it relates to barriers 
to accessing TB/HIV integrated services, Also, 'Challenges to access' of TB-HIV integrated 
services is not statistically significant and associated with the gender of the respondents 
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Table 4.5.5.3 Analysis of challenges associated with providing TB-HIV integrated services with age group in the three programmes 
  HIV (ART & pre ART Category) TB Category 
Females Males 
p-
value 
Females Males p-value 
Variable Response 
n % N % n % n %
Inconvenient 14 53.8 7 87.5 2 11.8 9 23.7
Enhance stigma 0 0 5 13.2
Poor care given/non-
comprehensive care 
1 3.8 0 .0 1 5.9 0 .0
Not getting medication on 
time/defaulting 
6 23.1 1 12.5 10 58.8 21 55.3
Lost in referral process 0 0 0 0 8 47.1 10 26.3
Challenges 
to access 
Assorted personal issues 5 19.2 1 12.5
0.006
0 0 0 0
0.393
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4.5.1.2.1 Choice of clinician and location of TB/HIV integrated services from the gender angle 
The result suggests that a most of the respondents comprising of females (69.5%) and males 
(66.7%) of the HIV category preferred different clinicians. Among the TB category, females 
(58.1%) and males (60%) preferred different clinicians. This suggests that there is no 
statistical difference.  In the choice of location of the TB-HIV integrated facilities most of the 
females an all the males in the HIV and TB categories preferred the facilities to be located in 
the same locale, All the p-values suggest that the individual results across the three categories 
were not statistically significant. 
Table 4.5.6 Perception on preferences on provision of TB/HIV integrated services from the gender 
angle 
  HIV (ART & pre ART Category) TB Category 
Females Males p-value Females Males p-value 
Variable Response 
n % n % n % n % 
Same 29 30.5 9 33.3 13 41.9 14 40.0 Choice of 
clinician Different 66 69.5 18 66.7
0.816
18 58.1 21 60.0 
1.000
Same 86 90.5 27 100.0 30 96.8 36 100.0 Choice of 
location Different 9 9.5 0 .0
0.204
1 3.2 0 .0 
0.463
 
4.5.1.2.2 Choice of community health workers support in providing TB/HIV integrated services 
from the gender angle 
The result as detailed in table 4.5.7 below indicates that females (100%) and males (87%) of 
the HIV category as well as females (100%) and males (85%) of the TB category of 
respondents preferred community health workers (CHW)’s assistance in continuation of 
TB/HIV integrated services beyond the facilities. The p-value for the ‘Desire for community 
health workers support’ for the HIV category suggests that it is statistically significant. 
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Table 4.5.7 Perception on preferences of community health workers support from the gender angle 
  HIV (ART & pre ART Category) TB Category 
Females Males 
p-
value 
Females Males 
p-
value Variable Response 
n % n %  n % n %  
Yes 83 100.0 20 87.0 19 100.0 17 85.0 Desire for community 
health workers support No 0 .0 3 13.0 
0.009 
0 .0 3 15.0 
0.231 
 
4.6 Conclusion 
The results as presented above indicate that the respondents, especially the females aged 30 
years and below: 
• Prefer to be attended by different clinicians rather than the same clinician in the 
course of accessing TB-HIV integrated services; 
• Have appropriate access to TB/HIV integrated care that is in line with guidelines; and 
are adequately enlightened about the likes of CD4 test, ARVs, adherence Support, 
TB-HIV care, healthcare beyond the health facilities, etc; 
• Associate TB/HIV integrated care with such features like ‘Accessibility’, ‘Ensure 
Privacy/confidentiality’, ‘Save money/ Minimise transport costs’, ‘Time-saving’, 
‘Reduce stigma’, etc; 
• Relate TB/HIV integrated care with such challenges like ‘Lack of privacy’, ‘Enhance 
stigma’, ‘Poor care given/non-comprehensive care’, ‘Lost in referral process’. Others 
are ‘Inconvenient, ‘Enhance stigma’, ‘Poor care given/non-comprehensive care’, 
‘Lost in referral process’, ‘Not getting medication on time/defaulting’, etc.  
• Prefer accessing TB-HIV integrated facilities and services in the same place rather 
than in different locations. This especially applies to those aged 30 years and above; 
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CHAPTER 5  DISCUSSION 
5.1 Discussion 
The purpose of this study was to assess the provision of TB and HIV integrated care from 
clients’ perspective. This is in order to make recommendations on ways to enhance the 
management of TB-HIV co-infected clients and treatment outcomes in Sisonke district, 
reflecting the understanding that the basic link of HIV/AIDS to several other health issues 
makes TB-HIV integration a priority (Sweeney, Carol, Obure, Maier, Greener, Dehne & 
Vassall, 2012). There is equally a general agreement that TB-HIV integration can enhance 
the quality and continuity of care for PLWHAs and extend HIV services to those who 
would likely not have access to them, especially PMTCT clients (World Bank, 2009). 
Generally, there is a wide range of public health and clinical benefits associated with TB-
HIV integration (The African Union Commission, 2006). 
5.1.2 Insights on TB/ HIV/ PMTCT services at the facility level 
The purpose of implementing collaborative TB and HIV activities is to lessen TB burden 
in HIV positive people and equally lessen the HIV burden in TB clients (WHO, 2004). 
This is achievable by viewing TB-HIV / TB integrated services from the eyes of those 
accessing the service. In this context, the respondents agreed that the services that they 
receive regarding the provision of integrated TB/ HIV/ PMTCT care at the facility level 
from health workers were optimal. This is in agreement with efforts made to scale up TB-
HIV integrated activities throughout South Africa (WHO, 2009b). In a related 
development, the establishment of TB/HIV pilot districts in collaboration with the WHO’s 
ProTEST initiative enhanced the provision of TB-HIV and PMTCT integrated services in 
South Africa (Hausler et al.2004). In relation to this study and on discussions on the 
specific services the respondents received in the TB-HIV collaborating facilities, majority 
of the respondents affirmed that these services were adequate. This considers the 
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frequency of the responses according to their categories, devoid of breaking them down 
further into age groups or gender. Broken down according to the responses as follows: 
• ARVs education: Most of the respondents, as presented in Chapter 4 above 
reported that they had enlightenment on ARVs. Seen from the age group angle, 
these were PMTCT category <31 years (67.6%) and those > 30 years (32.4%). 
ART & pre ART respondents <31 years (29.2%) and those > 30 years (70.8%). TB 
respondents <31 years (32.5%) and those that are > 30 years (67.5%). Unlike 
PMTCT respondents, older ART  pre ART and TB respondents report more about 
being enlightened about ARVs. ARVs are available and administered to registered 
attendants as a component of providing integrated TB and HIV/AIDS support, care 
and prevention. This is in consonance with the necessity for TB- HIV integrated 
services, which is to advance the quality of the services, guarantee the continuity / 
sustainability of care, as well as preventing and decreasing the burdens of TB and 
HIV on the clients and the society (WHO, 2004). On the contrary, the minute 
number of those that reported that they did not learn about ARVs is disputable as 
the administration of ARVs is an integral part of HIV-TB integrated services for 
those that are eligible. On a general note, it is a standard practice for PLWHAs to 
be educated about, and to have pro bono ARVs as part of the TB-HIV integrated 
treatment process if they are eligible. 
• Support on TB-HIV adherence: Seen also from the age groups angle, most of the 
PMTCT (65.4%) of < 31-year olds and 34% of > 30-year olds, pre ART & ART 
(25%) of < 31-year olds and 70% of > 30-year olds, as well as TB (31%) of < 31-
year olds and 69% of > 30-year olds respondents respectively reported 
enlightenment on TB-HIV adherence support. Treatment adherence support is an 
attribute of integrated TB-HIV/ PMTCT services. Even in the TB-HIV Pilot 
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Districts Initiative, one of the several benefits gained by the stakeholders  were that 
the home-based carers received trainings on TB, with DOTS supporters trained on 
TB (Hausler et al., 2004). Some of the features of treatment adherence support are 
that it enhances the confidence of the clients of TB-HIV integrated services in the 
treatment that they undergo, increases these clients’ motivational levels and 
promotes their coping skills (Daar, Cohen, Remien, Sherer & Smith, 2003). 
Treatment adherence support also helps the clients of TB-HIV integrated services 
to cope with the various challenges associated with taking TB-HIV integrated 
medicines including the long duration of taking such drugs and the phobia 
associated with the likes of agonising injections. Treatment adherence support 
equally helps these clients to cope effectively with effects of drug interactions and 
toxicities of TB-HIV dual therapy medicines (WHO, 2002). There is therefore the 
need to empower HCWs more by training them on the various components of TB-
HIV/PMTCT integrated care. With proper monitoring and feedback mechanisms, 
the trainings they receive will enhance managing TB-HIV / PMTCT clients. 
In a similar fashion, most of the respondents reported that they went for CD4 test after the 
advice of the healthcare worker on the day of the visit. This is a prerequisite to taking 
ARVs if one is HIV positive. When viewed from the angle of age groups, 63.6% of those 
younger than 31 years and 36.4% of the respondents older than 30 years reported that they 
underwent CD4 testing amongst PMTCT category. Similarly, 29.9% and 70.1% 
respectively of pre-ART & ART respondents reportedly underwent CD4 testing. Also 
amongst the TB categories, 31.6% and 68.4% respectively of those younger than 31 years 
versus those older than 30 years reported that they underwent CD4 testing. 
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Seen from the angles of age groups and gender, most of the respondents reported that they 
had optimal services in the course of their accessing TB-HIV/PMTCT integrated services. 
This is as contained in the tables in Chapter 4 above, as earlier mentioned. 
5.1.3.1 Education on the availability of TB services for HIV patients  
Education on availability of TB services for PMTCT and ART & pre-ART clients as an 
integral part of the TB/HIV/PMTCT services directly involved the PMTCT and ART & 
pre-ART clients. In terms of gender, most of the female respondents in the pre ART & 
ART and TB categories reported more that they had education on the availability of TB 
services in the facilities. Similarly, when viewed from the age group angle, the results 
show that the older respondents especially among the females know about the availability 
of TB services in the facility. 
5.1.3.2 Education on HIV services availability for TB patients 
Education on availability of HIV services for TB patients in the facilities is also an integral 
part of the TB/HIV/PMTCT services. The reason for this is that not all TB patients might 
be HIV positive. Similarly, not all HIV positive clients might be suffering from TB though 
they have a higher chance of contracting TB as a result of their being immune-
compromised.  As earlier reported above in Chapter 4, almost all the female HIV (ART & 
pre ART) and female TB respondents reported that they received education related to the 
provision of HIV services in the facilities. Majority of the male respondents in both 
categories also reported receiving education related to the provision of HIV services in the 
facilities.  Most of these respondents for both categories also reported that they were 
educated about undergoing CD4 testing, about ARVs and on adherence support. 
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5.1.4 Issues associated with accessing TB/HIV/PMTCT services 
The respondents reported on the issues that they associate with accessing TB-HIV and 
PMTCT integrated services. Age group and gender of the respondents, according to their 
categories separate this. 
These issues include the following: 
 Lack of privacy 
 Poor care given/non-comprehensive care 
 Lost in referral process 
Other issues associated with TB/HIV/PMTCT integrated services and recorded as 
challenges are: 
 Inconvenient 
 Enhance stigma 
 Poor care given/non-comprehensive care 
 Not getting medication on time/defaulting 
 Lost in referral process 
 Assorted personal issues 
The assorted personal issues as part of the items listed above seem to be in agreement 
with global trends as reflected in the literature review and in the conceptual framework 
of this study (Levin, Irving, Dikgang, Punwasi, Isaacs & Myer, 2006).  
5.1.4.1 Issues associated with accessing TB/HIV/PMTCT services from a broad 
perspective 
Clients of TB-HIV integrated services might not have access to proper nutrition due to 
sociological factors. Directly linked to malnutrition is the negative effects of poverty on 
families and communities, which is also daunting. Poverty may be characterised by 
constant hunger, trauma, and issues of family food insecurity including meeting up to the 
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infant’s dietary needs as it specifically relates to PMTCT (Rose-Jacobs, Black, Casey, 
Cook, et al., 2008). Also from the client’s perspective generally and specifically in terms 
of PMTCT, the difficulties that are encountered include the constraints of adhering to 
infant feeding recommendations, (Stringer, Chi, Chintu, Creek, Ekouevi, Coetzee, et al., 
2008). Studies also indicate that HIV-related maternal depression may be part of the 
problems faced by PMTCT-HIV-positive mothers (Murphy, Austin, & Greenwell, 2006). 
Another difficulty relates to the maternal level of literacy (Eickmann, Lima, Guerra, Lima, 
Lira, 2003). This is because the level of literacy of the woman might determine her 
predisposition to optimal maternal care including observance of environmental issues like 
proper sanitation and ventilation (Rahman, Harrington & Bunn, 2002). 
5.1.4.2 Issues from the age group perspective 
The trend suggests that younger respondents’ associate issues with accessing TB-HIV 
integrated care when compared with the younger respondents among the PMTCT 
respondents. On the other hand, older pre ART & ART regard accessing TB-HIV 
integrated care as daunting. There is a near-proportionate reportage among TB respondents 
of both age ranges with respect to associating TB-HIV integrated care with banes.  
5.1.4.3 Issues from the gender perspective 
The female respondents especially among the ART & pre ART category seemed to 
associate TB/HIV/PMTCT integrated care with issues. These issues discussed above 
coincide with constraints reported in other studies and include: 
• Confidentiality, stigma and refusal to treat the clients by the staff of TB-HIV 
integrated services at the health facilities (Pool, Nyanzi & Whitworth; 2001). 
• Non-convenient appointment times, long waiting periods and lack of privacy 
(Greene, 2004; Munro et al., 2007). 
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• Difficulties associated with taking medications, lengthy period of treatment and 
sometimes the fear of agonising injections (Munro et al., 2007) and the constraints 
associated with concurrent usage of ARVs and TB-treating drugs like medicine 
toxicities, threats of immune reconstitution events, interaction of drugs, etc (WHO, 
2002). 
• The challenges especially faced by PMTCT-HIV-positive mothers, like HIV-
related maternal depression (Murphy, Austin, & Greenwell, 2006). 
• The challenges faced outside the facilities including stigma, discrimination and 
threats to established interpersonal relationships (Iliyasu, Kabir, Galadanci, 
Abubakar, & Aliyu, 2005). 
These issues associated with attending TB/HIV/PMTCT integrated services as discussed 
above shows that despite the achievements, there is the need to address some gaps to achieve 
effective service delivery of TB/HIV/PMTCT care. 
5.1.5 Options linked with TB/HIV/PMTCT integrated services 
People accessing TB and HIV integrated services have an overwhelming desire for the 
sustainability of the services and for the facilities to be in the same location rather than in 
different sites. However, if given choices, they prefer to consult different clinicians for the 
two entirely different health conditions rather than one clinician. 
5.1.5.1 Choice of location of TB/HIV/PMTCT integrated facilities 
There is an overwhelming preference for the TB/HIV/PMTCT integrated services to be 
located in the same place. When viewed from the gender and age group perspective, there 
was no much difference in the responses. The overall result suggests that most of the older 
respondents preferred TB/HIV/PMTCT facilities to be located in the same place.  
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5.1.5.2 Choice of clinician within TB/HIV/PMTCT integrated facilities 
The choice of preferring same or different clinicians was viewed from both the age group and 
gender perspectives. 
5.1.5.2.1 Choice of clinician within TB/HIV/PMTCT integrated facilities from the age 
group perspective 
The choice of clinician within TB/HIV/PMTCT integrated facilities from the age group 
perspective shows that among the PMTCT clients, the younger ones prefer consulting 
different clinicians for both health conditions. Though the difference is not much, older 
respondents of TB category reportedly prefer different clinicians for both health conditions. 
The reason for this cannot easily be deduced and might merit further research. 
5.1.5.2.2 Choice of clinician within TB/HIV/PMTCT integrated facilities from the 
gender perspective 
Though not detailed here but as presented in Chapter 4, the outcome of the analysis shows 
that the female respondents preferred different clinicians attending to them, rather than by the 
same clinician while accessing TB-HIV and PMTCT integrated services. 
The desire for people preferring TB-HIV and PMTCT integrated services is to take advantage 
of the worldwide aim to lessen TB burden in HIV positive people and equally lessen the HIV 
burden in TB clients (WHO, 2004). It will also help to ensure that the beneficiaries of TB-
HIV integrated services undergo optimal treatment mechanisms. Also, the respondents that 
preferred different clinicians at the same facility might be because of the unprofessional 
attitudes of the available staff to the clients of TB/HIV/PMTCT services at the health 
facilities (Pool, Nyanzi & Whitworth; 2001). It might also be because the available staffs are 
not from the locale of the clients and as a result would not be effectively communicating with 
them in the same language (Orell, Bangsberg, Badri & Wood, 2003). This discussion on the 
 
 
 
 
 
 
72
choice of clinician within TB/HIV/PMTCT integrated facilities from the gender perspective 
relies on hypothesis based on the literature reviewed earlier in this study. 
5.1.6 Option of community health workers support in extending TB/HIV/PMTCT care 
at community level 
A significant number of respondents were interested in continuing TB/HIV/PMTCT 
integrated care in their homes, with the assistance of the CHWs. Most of the respondents’ 
preferred home visits by community health workers in continuation of their treatment. 
When viewed from the gender and age group perspective, there is not much difference in 
the responses. Significantly, the younger respondents embraced home visits more than the 
older ones. Specifically seen from the age group angle, the PMTCT respondents that 
preferred home visit by CHWS were 67.7% of the younger respondents and 32.3% of the 
older respondents. The pre ART & ART respondents that preferred home visit by CHWS 
were 30.1% of the younger respondents and 69.9% of the older respondents. The TB 
respondents that preferred home visit by CHWS were 33.3% of the younger respondents 
and 66.7% of the older respondents. It appears that apart from the PMTCT respondents, 
older ART & pre ART and TB respondents embrace the option of community health 
workers support in extending TB/HIV/PMTCT care at community level through home 
visits. The minority of the respondents that declined visits at home in continuation of their 
treatment might be because of issues revolving around stigma. Stigma and the so-called 
‘disclosure to other people’ are the most frequently reported issues. It is likely one of the 
major reasons for respondents refusing visits at home in continuation of TB/HIV/PMTCT 
integrated care.  
Some of the features of needing TB/HIV/PMTCT care outside the health facilities and 
subsequently at the homes of the clients are that: 
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• It makes it possible for people accessing TB/HIV/PMTCT care to have a positive 
mindset about their condition and be able to accept counselling by HCWs as it 
relates to living positively with their conditions (Zandile, 2004).  
• Accessing TB/HIV/PMTCT care makes it possible for the adequate training of 
HCWs in counselling and interpersonal communication skills. This capacity 
building invariably extends to the primary beneficiaries and leads to improved 
quality of TB/HIV/PMTCT care (MOHSS, 2004). 
Effective home service-delivery of TB/HIV/PMTCT care is an inalienable complement to 
the health facilities-based integrated services. A very important advantage of extending 
TB/HIV/PMTCT to the home of the clients is that it will underplay the ‘death sentence’ 
associated with HIV diagnosis, which is regarded as being equivalent to a death sentence if 
the result turns out to be positive (Bradford, 2004). It is therefore vital to extend 
TB/HIV/PMTCT integrated services beyond the health facilities, especially as it is 
possible and effective both within the health facilities and at the homes of the clients 
(Friedland, Harries & Coetzee, 2007b).  
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CHAPTER 6  CONCLUSION AND RECOMMENDATIONS 
6.1 Conclusion 
This study assessed the provision of TB and HIV integrated care including PMTCT in 
Sisonke district, KwaZulu Natal from the perspective of the clients. This was in order to 
make recommendations on possible ways to enhance the management of TB-HIV co-
infected clients and treatment outcomes. Viewing TB-HIV and PMTCT integrated services 
from the perspective of the beneficiaries was a strategy used to achieve this aim. 
Topics under consideration included perceptions of respondents on the services offered by 
health workers on the day of the visit; the study showed that the respondents were happy 
with the TB/HIV/PMTCT integrated services they received from the health workers 
despite the existence of some gaps. Other issues that were studied included education and 
provision of CD4 test, ARVs, TB drugs and availability of treatment adherence support by 
health worker. It was also determined that most of the respondents have access to these 
services as an integral part of the TB-HIV and PMTCT integrated services. The issues 
faced by clients while accessing TB/HIV/PMTCT services were cross tabulated with 
gender and age groups; it was ascertained that most of the people that access these services 
were females and that most of them were younger people. On the preference of 
respondents on provision of TB/HIV/PMTCT care, the study found out that this is widely 
accepted. The study found out that most of the respondents especially the older ones 
preferred receiving treatment at the same place.  The respondents also registered their 
preferences to have an HIV test at the same facility and their preference for home visit by 
community health workers in support of the provision of TB/HIV/PMTCT care, but not to 
undergo treatment by the same clinician for TB/HIV/PMTCT care. 
Contrary to expectations, clients that are accessing TB/HIV/PMTCT care are pleased with 
the services and prefer accessing TB/HIV/PMTCT services, despite the drawbacks 
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associated with HIV and TB. Another point worth mentioning is that contrary to 
expectations, younger respondents preferred to continue receiving TB-HIV integrated care 
at their homes in comparison with older respondents. 
6.2 Recommendations 
1. There is the need to replicate, establish and continue promoting integrated TB-
HIV and PMTCT services. 
2. There is the need for the recruitment and training of more HCWs in delivering 
TB-HIV and PMTCT integrated services. 
3. It is suggested that integrated TB-HIV and/PMTCT services should focus on 
clients satisfaction in order to enhance its delivery. 
4. The challenges associated with integrated TB-HIV and/PMTCT services 
especially as it relates to staff shortages, stigma and confidentiality issues 
should be addressed with adequate policies entrenched to safeguard the 
interests of the clients. 
5. It is suggested that the community should be more enlightened and made to be 
actively involved in integrated TB-HIV and/PMTCT services. This will help to 
reduce the stigma associated with TB, HIV and AIDS. It will also enhance 
HIV-related health promotion within the society. 
6. There is the need to promote interventions that should actively involve more 
males in TB/HIV/PMTCT integrated services. This will amongst others remove 
the labelling of HIV as an all-female affair and effectively involve more 
stakeholders in the fight against the HIV pandemic. 
7. It is recommended that more research on ways to promote the satisfaction of 
clients accessing integrated TB-HIV and/PMTCT services needs to be done. 
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8. It is of utmost importance to extend integrated TB-HIV / PMTCT services to 
other health facilities that are not yet offering such services. 
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APPENDICES 
Appendix 1: Table containing sample size for the exit interview. 
Sample size for exit interviews (data collection grid) 
Name of sub-district ANC TB 
Pre-ART & 
ART 
Total 
Egum 32 12 17 61 
Kokstad TLC 16 5 8 29 
CTK 3 13 32 48 
Jolivet 6 8 10 24 
Reitvlei 16 2 23 41 
Riverside  15 8 11 34 
SAH 12 13 19 44 
Pholela 9 8 5 22 
Underberg 26 3 10 39 
Kilmun 6 5 7 18 
Row Total 141 77 142 360 
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Appendix 2. Participant information sheet. 
 
Study title: Assessment of clients’ perspective on provision of TB and HIV integrated 
services including PMTCT in Sisonke district, KZN- South Africa. 
Dear participant 
I would like to invite you to participate in this study. Your involvement will take about 30-45 
minutes. Your participation in this study is completely voluntary. Before agreeing to 
participate, it is important that you read and understand the purpose of the study and the 
procedure. This information sheet is to help you decide if you would like to participate.  
Permit me at this point to introduce myself. I am Anikamadu, Michael. A Masters in Public 
Health student of the University of the Western Cape. This is an academic research being 
conducted for mini-thesis purposes.  I am in the process of collecting information on the 
assessment of clients’ perspective on provision of TB and HIV integrated services including 
PMTCT in Sisonke district, KZN- South Africa.  
If you have any questions, do not hesitate to ask the researcher. You are at liberty to 
participate or not to participate in this research. If you agree to participate in the study, you 
are still free to withdraw from the study at any stage and this will not be held against you in 
any way. You may also decline to answer and / or discuss particular question(s) should you 
wish to do so. If you decide to take part in this study, you will be requested to sign the 
consent form to confirm that you understand the study and agree to take part. Equally, you 
will be given a copy of the said consent form to keep. 
Purpose of the study 
The researcher aims to assess the provision of TB and HIV integrated care from clients’ 
perspective in order to make recommendations on ways to enhance the management of TB-
HIV co-infected clients and treatment outcomes in Sisonke district.  This study will therefore 
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assist in enhancing the provision of TB-HIV integrated services as it will be seen from the 
eyes of the clients.  
Risks and Benefits 
There are no probable risks involved in participating in this study. The information gained 
will not be used for any other purpose other than the study.  
The benefit of the study on the other hand is to identify the likely gaps in the delivery of 
integrated TB and HIV activities by viewing it for the clients’ perspective and to 
subsequently make appropriate suggestions.  
Confidentiality 
All information provided by you will be kept strictly confidential and will only used by the 
researcher.  Data that may be reported in the research report will not include any information 
that identifies you as a participant in this study. The names in the informed consent and other 
personal information during the course of the study will also be kept confidential. In order to 
ensure that you remain anonymous, after the study is completed any form of identity relating 
to you will be removed to ensure you remain anonymous.  
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Appendix 3: Informed Consent to the participant 
 
 
Informed consent  
I have been informed about the intention of 
the study. I have equally been told about 
what my participation involves. I also 
understand that I can leave from the study at 
any time, without having to give an 
explanation. I also understand that this study 
is completely voluntary.  
I as well understand that my privacy will be 
maintained and that the findings of the study 
will only be used for the purposes research. 
  
 _______________________________               _________________ 
Participant’s signature of                         Date 
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Appendix 4:  The questions as contained in the questionnaire for the exit interview with 
TB and HIV clients 
 
1. Can you tell me how you experienced your visit today at the clinic/hospital? 
 
 
2. For TB clients 
2.1 Did a health worker talk to you about TB 
directly observed treatment or DOT support? 
Yes No 
2.2 If yes, who is your DOT supporter? Husband 
Family member 
Community health worker 
Home based carer 
Community volunteer 
Nurse at the clinic 
2.3 Did a health worker talk to you about the signs 
and symptoms of sexually transmitted 
infections? 
Yes No 
2.4 Did a health worker talk to you about the 
importance of using condoms for HIV 
prevention? 
Yes No 
2.5 Did a health worker talk to you about the HIV 
testing? 
Yes No 
2.6 Have you been tested for HIV? If yes, go to 2.8 Yes No 
2.7 If no, can you tell me why you have decided not 
to have HIV test 
 
2.8 If yes, where did you get tested? TB clinic 
Referred to VCT 
ARV clinic 
Others (specify) 
2.9 If tested, did you get your test results Yes No 
2.10 If you feel comfortable telling me, what was the 
result of your test? 
Positive 
Negative 
Don’t know 
Chooses not to disclose 
2.11 Did a health worker talk to you about sharing 
your test results with your partner or family? 
Yes No 
2.12 Did a health worker talk to you about a CD4 
test? 
Yes No 
2.13 Have you had a CD4 test? Yes No 
2.14 If yes, where? TB clinic 
ARV clinic 
2.15 What is your CD4 result? CD4 count: 
 
Don’t know 
2.16 Did a health worker talk to you about drugs 
called antiretrovirals (ARVs) that are available 
to treat people living with HIV? 
Yes No 
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2.17 If (CD4 is less than 200), have you been 
referred to an antiretroviral (ARV) clinic? 
Yes No 
2.18 Are you on both TB medications and ARVs? Yes No 
2.19 Did a health worker refer you to a community 
supporter for adherence support? 
Yes No 
2.20 Does your DOT supporter (see 2.2) also support 
you for antiretroviral (ARV) treatment? 
Yes No 
2.21 If no, who is your supporter in the community? Husband 
Family member 
Friend 
HCW 
Home based carer 
Mother to mothers 
Nurse 
Others (specify) 
2.22 Would you prefer to have the same person 
supporting you for TB treatment and 
antiretroviral (ARV) treatment? 
Yes No 
 
 
3. For HIV positive clients 
3.1 Did a health worker talk to you about a CD4 test? Yes No 
3.2 Have you had a CD4 test? Yes No 
3.3 What is your CD4 result? CD4 count: Don’t know 
3.4 Did a health worker talk to you about drugs called 
antiretrovirals (ARVs) that are available to treat 
people living with HIV? 
Yes No 
3.5 (If CD4 is less than 200), are you on antiretroviral 
(ARV) treatment? 
Yes No 
3.6 Did a health worker talk to you about antiretroviral 
adherence support available in the community? 
Yes No 
3.7 Did a health worker refer you to a community 
supporter for adherence support? 
Yes No 
3.8 If yes, who is your supporter in the community? Husband 
Family member 
Friend 
HCW 
Home based carer 
Mother to mothers 
Nurse 
Others (specify) 
3.9 Did a health worker talk to you about family 
planning options? 
Yes No 
3.10 Did a health worker tell you what are the signs and 
symptoms of TB? 
Yes No 
3.11 What are the signs and symptoms of TB? 
(Tick all that are mentioned) 
Cough for a month 
Coughing up blood 
Night sweats 
Weight loss 
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Loss of appetite 
Chest pain 
Enlarged lymph nodes 
Weakness 
3.12 Did a health worker ask you if you are coughing? Yes No 
3.13 If you are coughing, did a health worker ask you for 
sputum for TB test? 
Yes No 
3.14 If yes, is your TB test positive? Yes No 
3.15 If yes, were you referred to a TB clinic to start TB 
treatment? 
Yes No 
3.16 If no, did you start your TB treatment at the same 
clinic? 
Yes No 
3.17 Did a health worker talk to you about adherence 
support available in the community? 
Yes No 
3.18 Did a health worker refer you to a community 
supporter for adherence support? 
Yes No 
3.19 Does your DOT supporter also support you for 
antiretroviral (ARV) treatment? 
Yes No 
3.20 If no, who is your supporter in the community? Husband 
Family member 
Friend 
HCW 
Home based carer 
Mothers to mothers 
Nurse 
Others (specify) 
3.21 Would you prefer to have the same person 
supporting you for TB treatment and antiretroviral 
(ARV) treatment? 
Yes No 
 
 
4. General knowledge on HIV and TB 
4.1 Is a person living with HIV more likely to have TB than an 
HIV negative person? 
Yes No I don’t 
know 
4.2 Can TB be cured in people living with HIV? Yes No I don’t 
know 
4.3 Do you know that all pregnant women should have an HIV 
test? 
Yes No I don’t 
know 
4.4 Can HIV be transmitted through breastfeeding? Yes No I don’t 
know 
4.5 If an HIV-positive mother breastfeeds and formula feeds, is 
she more likely to transmit HIV than if she exclusively 
breastfeeds or formula feeds? 
Yes No I don’t 
know 
4.6 Do you think that it is necessary for every baby born from 
an HIV positive mother to get an HIV test? 
Yes No I don’t 
know 
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5. Perceptions on service delivery mechanism 
5.1 If you were on TB treatment and you were HIV positive would 
you prefer to receive treatment for both diseases at the same 
clinic or in different clinics? 
Same Different 
5.2 Would you prefer to be able to be tested for HIV in the antenatal 
clinic or in a separate place? 
Same Different 
5.3 If you were HIV positive, would you prefer to receive treatment 
for both diseases by the same nurse or by different nurses? 
Same Different 
 
5.4.  What are the advantages of having services for TB and HIV in the same clinic? (List at least 3 
advantages) 
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------- 
 
5.5.  What are the disadvantages of having services for TB and HIV in the same clinic? (List at least 
3 advantages) 
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------- 
 
5.6. VCT/ARV and TB services are in different places. How far away are they from each other? 
1. 5 minutes to 10 minutes [ ] 
2. 10 minutes to 15 minutes [ ] 
3. 15 minutes to 20 minutes [ ] 
4. 20 minutes to 25 minutes [ ] 
5. 25 minutes to 30 minutes [ ] 
6. I don’t know  [ ] 
 
5.7.  VCT/ARV and TB services are in different places, what difficulties would you face in going to 
both? (List at least 3 difficulties) 
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------- 
5.8. Would you want to have a HCW visiting you at your household for support during illness? 
  1. Yes [ ] 2. No [ ] 
5.9. If no, what are the reasons? (List at least 3 reasons) 
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------- 
 
5.10.  Have you ever been visited by a HCW in your household? 1. Yes [ ] 2. No [ ] (if no, go to 
5.12) 
 
5.11. If yes, which support did she/he provide? 
1. Health education     [ ] 
2. Screen for TB     [ ] 
3. Voluntary counselling & HIV testing  [ ] 
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4. Support for antiretroviral treatment  [ ] 
5. TB directly observed therapy (DOT)  [ ] 
6. Others (please specify)    [ ] 
 
5.12.  If you have received support from a community health worker, what did you dislike about the 
support given? (List at least 3 mostly like) 
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------- 
5.13.  If you have received support from a community health worker, what did you like about the 
support given? (List at least 3 mostly like) 
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------- 
 
5.14.  If you are living with HIV, which of the following services would you be willing to receive 
from a HCW and allow him/her to do in your household? 
1. Support for antiretroviral treatment adherence 1. Yes [ ] 2. No [ ] 
2. Screen for TB by asking about TB symptoms 1. Yes [ ] 2. No [ ] 
3. Collect sputum to be taken to clinic  1. Yes [ ] 2. No [ ] 
4. Support for TB treatment    1. Yes [ ] 2. No [ ] 
5. Others (please specify) 
 
5.15. If you are having TB, which of the following services would you be willing to receive from a 
HCW to do in your household? 
1. Support for TB treatment adherence     1. Yes [ ] 2. No [ ] 
2. Provide counselling on HIV testing     1. Yes [ ] 2. No [ ] 
3. Provide counselling and HIV testing     1. Yes [ ] 2. No [ ] 
4. Support for antiretroviral (ARV) treatment    1. Yes [ ] 2. No [ ] 
5. Screen for TB by asking about TB symptoms to household members 1. Yes [ ] 2. No [ ] 
6. Collect sputum to be taken to the clinic    1. Yes [ ] 2. No [ ] 
7. Support for HIV care       1. Yes [ ] 2. No [ ] 
8. Others (please specify 
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Appendix 5:  The questions as contained in the questionnaire for the exit interview with antenatal 
PMTC clients or pregnant women at the antenatal clinics. 
 
1. Can you tell me how you experienced your visit today at the clinic/hospital? 
 
 
2. General pregnancy care 
2.1 Did a health worker talk to you about HIV 
testing? 
Yes No 
2.2 Have you been tested for HIV during this 
pregnancy? If yes, go to 2.4 
Yes No 
2.3 If not, can you tell me why you have decided 
not to have an HIV test (go to question 2.9) 
 
2.4 If yes, where did you get tested? ANC clinic 
Referred to VCT 
2.5 If tested, did you get your test results Yes No 
2.6 If you feel comfortable telling me, what was the 
result of your test? 
Positive 
Negative 
Don’t know 
Chooses not to disclose 
2.7 Did a health worker talk to you about sharing 
your test results with your partner or family? 
Yes No 
2.8 Did a health worker explain to you about the 
different ways that a baby can get HIV from the 
mother? 
Yes No 
2.9 Did a health worker talk to you about using 
condoms during pregnancy? 
Yes No 
2.10 Did a health worker talk to you about family 
planning options after the baby is born? 
Yes No 
2.11 Did a health worker talk to you about the signs 
and symptoms of sexually transmitted 
infections? 
Yes No 
2.12 Did a health worker tell you what the signs and 
symptoms of TB are? 
Yes No 
2.13 What are the signs and symptoms of TB? 
(Tick all that are mentioned) 
Cough of more than one  month 
Coughing up blood 
Night sweats 
Weight loss 
Loss of appetite 
Chest pain 
Enlarged lymph nodes 
Weakness 
2.14 Did a health worker ask you if you are 
coughing? 
Yes No 
2.15 If you are coughing, did a health worker ask 
you for sputum for TB test? 
Yes No 
 If yes, is your TB test positive? (If yes, go to 
3.15 – 3.17). 
Yes No 
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3. For HIV positive mothers 
3.1 Did a health worker talk to you about a CD4 test? Yes No 
3.2 Have you had a CD4 test during this pregnancy? Yes No 
3.3 What is your CD4 result? CD4 count: Don’t know 
3.4 Did a health worker talk to you about drugs called 
antiretrovirals (ARVs) that are available to treat 
people living with HIV? 
Yes No 
3.5 (If CD4 is less than 200 or doesn’t know CD4), 
have you been referred to an antiretroviral (ARV) 
clinic? 
Yes No 
3.6 Are you taking ARVs? Yes No 
3.7 Did a health worker talk to you about dual therapy 
(Nevirapine and AZT) to prevent transmission of 
HIV to your baby? 
Yes No 
3.8 Are you on dual therapy (NVP and AZT)? Yes No 
3.9 Did a health worker talk to you about adherence 
support available in the community? 
Yes No 
3.10 Did a health worker refer you to a community 
supporter for adherence support? 
Yes No 
3.11 If yes, who is your supporter in the community? Husband 
Family member 
Friend 
HCW 
Home based carer 
Mother to mothers 
Nurse 
Others (specify) 
3.12 Did a health worker talk to you about the 
importance of using condoms during pregnancy to 
avoid re-infection? 
Yes No 
3.13 Did a health worker talk to you about infant feeding 
options? 
Yes No 
3.14 If you have TB, were you referred to a TB clinic to 
start TB treatment? (If yes, go to 3.16 and if no, go 
to 3.15). 
Yes No 
3.15 Did you start your TB treatment here? Yes No 
3.16 Did a health worker talk to you about TB directly 
observed treatment or DOT support? 
Yes No 
3.17 If yes, who is your DOT supporter? Husband 
Family member 
Community health worker 
Home based carer 
Community volunteer 
Nurse at the clinic 
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4. General knowledge on HIV and TB 
4.1 Is a person living with HIV more likely to have TB than an 
HIV negative person? 
Yes No I don’t 
know 
4.2 Can TB be cured in people living with HIV? Yes No I don’t 
know 
4.3 Do you know that all pregnant women should have an HIV 
test? 
Yes No I don’t 
know 
4.4 Can HIV be transmitted through breastfeeding? Yes No I don’t 
know 
4.5 If an HIV-positive mother breastfeeds and formula feeds, is 
she more likely to transmit HIV than if she exclusively 
breastfeeds or formula feeds? 
Yes No I don’t 
know 
4.6 Do you think that it is necessary for every baby born from 
an HIV positive mother to get an HIV test? 
Yes No I don’t 
know 
 
 
5. Perceptions on service delivery mechanism 
5.1 If you were on TB treatment and you were HIV positive would 
you prefer to receive treatment for both diseases at the same 
clinic or in different clinics? 
Same Different 
5.2 Would you prefer to be able to be tested for HIV in the antenatal 
clinic or in a separate place? 
Same Different 
5.3 If you were HIV positive, would you prefer to receive treatment 
for both diseases by the same nurse or by different nurses? 
Same Different 
 
5.4.  What are the advantages of having services for TB and HIV in the same clinic? (List at least 3 
advantages) 
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------- 
 
5.5.  What are the disadvantages of having services for TB and HIV in the same clinic? (List at least 
3 advantages) 
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------- 
 
5.6. VCT/ARV and TB services are in different places. How far away are they from each other? 
1. 5 minutes to 10 minutes [ ] 
2. 10 minutes to 15 minutes [ ] 
3. 15 minutes to 20 minutes [ ] 
4. 20 minutes to 25 minutes [ ] 
5. 25 minutes to 30 minutes [ ] 
6. I don’t know  [ ] 
 
5.7.  If antenatal and TB services are in different places, what difficulties would you face in going to 
both? (List at least 3 difficulties) 
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------- 
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5.8. Would you want to have a HCW visiting you at your household for support during illness? 
  1. Yes [ ] 2. No [ ] 
 
5.9. If no, what are the reasons? (List at least 3 reasons) 
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------- 
 
5.10.  Have you ever been visited by a HCW in your household? 1. Yes [ ] 2. No [ ] (if no, go to 
5.12) 
 
5.11. If yes, which support did she/he provide? 
1. Health education    [ ] 
2. Screen for TB     [ ] 
3. Voluntary counselling & HIV testing  [ ] 
4. Support for antiretroviral treatment  [ ] 
5. TB directly observed therapy (DOT)  [ ] 
6. Others (please specify)    [ ] 
 
5.12.  If you have received support from a community health worker, what did you dislike about the 
support given? (List at least 3 mostly like) 
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------- 
 
5.13.  If you have received support from a community health worker, what did you like about the 
support given? (List at least 3 mostly like) 
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------- 
 
5.14.  If you are living with HIV, which of the following services would you be willing to receive 
from a HCW and allow him/her to do in your household? 
1. Support for antiretroviral treatment adherence 1. Yes [ ] 2. No [ ] 
2. Screen for TB by asking about TB symptoms  1. Yes [ ] 2. No [ ] 
3. Collect sputum to be taken to clinic   1. Yes [ ] 2. No [ ] 
4. Support for TB treatment     1. Yes [ ] 2. No [ ] 
5. Others (please specify) 
 
5.15. If you are having TB, which of the following services would you be willing to receive from a 
HCW to do in your household? 
1. Support for TB treatment adherence     1. Yes [ ] 2. No [ ] 
2. Provide counselling on HIV testing     1. Yes [ ] 2. No [ ] 
3. Provide counselling and HIV testing     1. Yes [ ] 2. No [ ] 
4. Support for antiretroviral (ARV) treatment    1. Yes [ ] 2. No [ ] 
5. Screen for TB by asking about TB symptoms to household members 1. Yes [ ] 2. No [ ] 
6. Collect sputum to be taken to the clinic    1. Yes [ ] 2. No [ ] 
7. Support for HIV care       1. Yes [ ] 2. No [ ] 
8. Others (please specify) 
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Appendix 6:  CONSENT FORM FOR ALL BENEFICIARIES (TB/HIV/ANC-PMTCT 
clients)  
 
UNIVERSITY OF THE WESTERN CAPE 
 
     Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959, Fax: 27 21-959 
                                                      E-mail:  
Title of Research Project:  
“Community participation in tuberculosis and HIV integrated activities, constraints 
and costs for enhancing the integration of tuberculosis and HIV programmes in a rural 
area of South Africa” 
The study has been described to me in language that I understand and I freely and voluntarily 
agree to participate. My questions about the study have been answered. I understand that my 
identity will not be disclosed and as a focus group member I need to respect the disclosures 
of other focus group members. In addition, I may withdraw from the study without giving a 
reason at any time and this will not negatively affect me in any way.   
Declaration by participant 
By signing below, I.................................................................................... agree to take part in 
a reserch study  “Community participation in the delivery of joint TB  and HIV/PMTCT 
                        services in Sisonke district,  KwaZulu-Natal, South Africa” 
I declare that: 
• I have read or had read to me this information and consent form and it is written in a 
laguange with which i am fluent and comfortable. 
• I have had a chance to ask questions and all my questions have been adequately 
answered. 
• I understand that taking part in this study is voluntary and i have not been pressurised to 
take part. 
• I understand  that the FGDs will be auditiotaped 
• I may choose to leave the study at any time and will not be penalised or prejudiced in 
any any way. 
• I may be asked to leave the study before it has finished, if the study rsearcher feels it is 
in my best interest or if I do not follow the study plan, as agreed to. 
 
Signed at (place)............................................... on (date).............................. 2008 
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---------------------------------------------------            ---------------------------------------------- 
Signature of participant         Signature of witness 
 
 
Declaration by investigator /  
 
I  (name )……………………………………………………. Declare that: 
 
• I explained the information in this document to ………………………………… 
• I encouraged him/her to ask questions and took adequate time to answer them 
• I am satisfied that he /she adequately understands all aspects of the research, as discussed 
above 
• I did not use the interpreter 
 
Signed at (place)............................................... on (date).............................. 2008 
 
---------------------------------------------------            ---------------------------------------------- 
Signature of participant         Signature of witness 
 
Should you have any questions regarding this study or wish to report any problems 
you have experienced related to the study, please contact the study coordinator: 
Jeannine Uwimana:  
University of the Western Cape 
Private Bag X17, Belville 7535 
Telephone: (021)959-2513 
Cell: 073-787-1342 
Fax: +27 21 959 2872 
Email: juwimana@uwc.ac.za 
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Appendix 7: The Information Sheet 
 
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959, Fax: 27 21-959 
                                                     E-mail:  
INFORMATION SHEET FOR TB, HIV and PMTCT clients 
Project Title: Community participation in tuberculosis and HIV integrated activities, 
constraints and costs for enhancing the integration of tuberculosis and HIV  
programmes in a rural area of South Africa.  
What is this study about?  
This is a research project being conducted by the School of Public Health at the University of 
the Western Cape.  We are inviting you to participate in this research project because you are 
a TB or HIV client or pregnant mother who attends the selected health facility for this 
project.  The purpose of this research is to develop and evaluate a community based 
intervention that will strengthen the district health system’s capacity to improve the provision 
of integrated TB and HIV care including PMTCT in Sisonke district. 
 
What will I be asked to do if I agree to participate? 
You will be asked to participate in an exit interview and you will be asked to fill a 
questionnaire that will contain the data below: 
• Socio-demographic data (i.e. age, sex, employment status, etc) 
• Health status  
• Service received  
• Perceptions on the service delivery mechanism and the referral system 
The exit interview will last approximately 15-30 minutes and we will do our best to keep 
your personal information confidential.  To help protect your confidentiality, your name will 
not be recorded. If we write a report or article about this research project, your identity will 
be protected to the maximum extent possible.   
 
What are the risks of this research? 
There are no known risks associated with participating in this research project.   
 
What are the benefits of this research? 
This research is designed to help firstly the researcher and the district health managers to 
assess the integration of TB and HIV services including PMTCT as well to better understand 
how the community could participate in the provision of TB and HIV/PMTCT integrated 
care.  
Secondly this research will also help beneficiaries of care such as you to receive a 
coordinated and cost-effective care at the community level as well at the facility level. 
Community participation in joint activities is necessary for enhanced provision of integrated 
care as well improved access to care.  
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Do I have to be in this research and may I stop participating at any time?   
Your participation in this research is completely voluntary.  You may choose not to take part 
at all.  If you decide to participate in this research, you may stop participating at any time.  If 
you decide not to participate in this study or if you stop participating at any time, you will not 
be penalized or lose any benefits to which you otherwise qualify. Your decision to participate 
or not to participate in this research project will not affect your treatment or quality of care 
that you are receiving from this clinic now and in the future.  The data will only be accessed 
by the principal investigator. 
 
What if I have questions? 
This research is being conducted by Jeannine Uwimana, School of Public Health at the 
University of the Western Cape.  If you have any questions about the research study itself, 
please contact Jeannine Uwimana at the following address: 
Tel: +27 21 959 2513 
Cell: +27 073 787 1342 
Fax: +27 21 959 2872 
Email: juwimana@uwc.ac.za   
 
Should you have any questions regarding this study and your rights as a research participant 
or if you wish to report any problems you have experienced related to the study, please 
contact:   
Head of Department: 
Dean of the Faculty of Community and Health Sciences:  
University of the Western Cape 
Private Bag X17 
Bellville 7535         
 
This research has been approved by the University of the Western Cape’s Senate Research 
Committee and Ethics Committee. 
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Appendix 8: Ethical Clearance letter for the major study 
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Appendix 9: World Health Organisation’s recommendation for TB-HIV integrated 
activities. 
To make the integration of TB-HIV activities effective, the World Health Organisation 
(2004) recommended the following: initiating co-trimoxazole / Isoniazid preventive therapy; 
initiating of antiretroviral therapy; introduction of HIV prevention methods; making available 
HIV testing and counselling; minimising the burden of HIV in tuberculosis clients and 
minimising the burden of tuberculosis in HIV positive people. 
Rather than parallel programmes to control both diseases, it is essential that integrative   
activities should be a part of the continuum of care for clients infected with TB and HIV 
diseases (WHO, 2004). 
To further justify the need for TB-HIV integration, the World Health Organisation, (2002) 
projected that one third of HIV positive people would eventually develop TB in the course of 
their lifetime. This is because: HIV increases TB infection; HIV encourages progression to 
active TB for people recently infected with TB; Increasing TB infection of HIV positive 
people puts communities at greater risk of acquiring TB; and HIV enhances the possibility of 
TB recurring. Similarly, HIV positive people are more susceptible to developing TB 
regardless of their having access to ARVs or otherwise. However, preventing and treating TB 
results to improved quality and longer life, with the attendant benefits to the families and 
communities of people living with HIV. 
 
 
 
 
